UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2025
SKEENA RESOURCES LIMITED
(Translation of Registrant’s Name into
English)
001-40961
(Commission File Number)
1133 Melville Street, Suite 2600, Vancouver,
British Columbia, V6E 4E5, Canada
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ¨ Form 40-F
x
DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K
Exhibit 99.1 to this report is incorporated
by reference as an additional exhibit to the registrant’s Registration Statement on Form F-10 (File No. 333-269481).
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
SKEENA RESOURCES LIMITED |
|
|
|
|
By: |
/s/ Andrew MacRitchie |
|
|
Name: Andrew MacRitchie |
|
|
Title: Chief Financial Officer |
Date: February 21, 2025
Exhibit 99.1
UNDERWRITING AGREEMENT
February 20, 2025
Skeena Resources Limited
2600 – 1133 Melville St.
Vancouver, BC V6E 4E5
Attention: Walter
Coles Jr., Executive Chairman
Dear Sirs/Mesdames:
BMO Nesbitt Burns Inc., as sole bookrunner and
lead underwriter (the “Lead Underwriter”), along with Raymond James Ltd., RBC Dominion Securities Inc., Agentis Capital
Markets LP, Canaccord Genuity Corp., CIBC World Markets Inc., Desjardins Securities Inc., and TD Securities Inc. (together with the Lead
Underwriter, the “Underwriters” and each individually an “Underwriter”) understand that Skeena Resources
Limited (the “Company”) proposes to issue and sell to the Underwriters or Substituted Purchasers, as defined below,
upon and subject to the terms hereof, an aggregate of 4,800,000 common shares (the “Common Shares”) of the Company
at a price of $14.70 per Common Share (the “Offering Price”) for aggregate gross proceeds of C$70,560,000.
The Underwriters may elect, at any time up to
48 hours prior to the Closing Time (as defined below), to have up to 2,230,000 Common Shares issuable under the Offering (including any
Common Shares issuable upon exercise of the Underwriters’ Option (as defined below)) be issued as “flow-through shares”
(the “Flow-Through Shares”) at a price of C$17.93 per Flow-Through Share (the “Flow-Through Price”).
Each Flow-Through Share will qualify as a “flow-through share” within the meaning of subsection 66(15) of the Income Tax Act
(Canada). The Common Shares and Flow-Through Shares are referred to in this agreement as the “Offered Shares”.
The Flow-Through Shares will have the attributes
described in the Final Prospectuses (as defined below) and will be initially issued to purchasers in Canada under Flow-Through Subscription
Agreements (as defined below). The Company has been informed that purchasers of Flow-Through Shares will sell their Flow-Through Shares
(collectively, the “Secondary Shares”) to purchasers arranged by the Underwriters at the Offering Price or a lower
price as contemplated by paragraph 6 below, retaining the right to receive the expenses to be renounced by the Company to the purchasers
of the Flow-Through Shares. The Offering Documents (as defined below) qualify the distribution of the Offered Shares.
The Company has granted the Underwriters an option, exercisable, upon
and subject to the terms and conditions contained herein and in accordance with Section 16 hereof, in whole or in part, at any time until
48 hours prior to the Closing Time (the “Underwriters’ Option”) to purchase severally, and not jointly nor jointly
and severally, in the respective percentages set forth in Section 22 hereof, up to an additional 720,000 Common Shares (the “Additional
Shares”). The Underwriters may each elect in their sole discretion to purchase Additional Shares as Common Shares at the Offering
Price, as Flow-Through Shares at the Flow-Through Price, or a combination thereof.
The offering of the Offered Shares (including
any Additional Shares) is hereinafter referred to as the “Offering”. Where applicable, references to “Offered
Securities” in this Agreement shall mean the Common Shares, the Flow-Through Shares and the Additional Shares.
Subject to the terms and conditions contained in this Agreement, the
Underwriters hereby severally, and not jointly nor jointly and severally, agree to purchase from the Company, in the percentages set forth
in Section 22 hereof, and, by its acceptance hereof, the Company agrees to sell to the Underwriters all but not less than all of (i) the
Common Shares at the Closing Time (as defined below) at the Offering Price for each Common Share and each Additional Share and, (ii) to
the extent that the Underwriters elect to purchase Common Shares as Flow-Through Shares, the Flow-Through Shares at the Closing Time at
the Flow-Through Price for each Flow-Through Share and Additional Share that is a Flow-Through Share. To the extent that the Underwriters
elect to purchase Common Shares as Flow-Through Shares, the Underwriters will endeavour to arrange for substituted purchasers (collectively,
the “Substituted Purchasers”) with the effect that such Substituted Purchasers will be the initial purchasers of the
Flow-Through Shares. To the extent that Substituted Purchasers purchase any Flow-Through Shares, the Underwriters shall not be obligated
to purchase the Flow-Through Shares so purchased by such Substituted Purchasers.
Subject to applicable laws, after a reasonable
effort has been made to sell all of the Offered Securities at the Offering Price, the Underwriters may subsequently reduce the selling
price to investors from time to time, provided that any such reduction in the Offering Price shall not affect the aggregate Offering Price
less the Underwriting Fee (as defined below) payable to the Company.
The Offering shall take place in all of the provinces
of Canada, except Quebec (the “Qualifying Jurisdictions”), and in the United States (as defined below) and in such
jurisdictions outside Canada and the United States as determined appropriate by the Underwriters.
The Underwriters understand that the Company has
prepared and filed with each of the Canadian Securities Commissions (as defined below) (i) a preliminary short form base shelf prospectus
dated January 11, 2023 (together with the Documents Incorporated by Reference (as defined below) therein, the “Canadian
Preliminary Base Shelf Prospectus”), and (ii) a final short form base shelf prospectus dated January 31, 2023 (together
with the Documents Incorporated by Reference therein and any supplements or amendments thereto, the “Canadian Final Base Shelf
Prospectus”), in respect of up to $200,000,000 aggregate offering price of common shares, preferred shares, debt securities,
warrants, subscription receipts and units of the Company, omitting the Shelf Information (as defined below) in accordance with the Shelf
Procedures (as defined below) and that the Company has received a Prospectus Receipt (as hereinafter defined) for the Canadian Preliminary
Base Shelf Prospectus on January 12, 2023 and for the Canadian Final Base Shelf Prospectus on January 31, 2023. The preliminary
Canadian prospectus supplement (the “Preliminary Canadian Prospectus Supplement”) relating to the Offering, which excludes
certain pricing information and other final terms of the Offered Securities and which has been filed with the Canadian Securities Commissions
(as defined below) on February 18, 2025, together with the Canadian Final Base Shelf Prospectus, including the Documents Incorporated
by Reference therein and any supplements or amendments thereto, is hereinafter referred to as the “Canadian Preliminary Prospectus”,
and the final Canadian prospectus supplement (the “Canadian Prospectus Supplement”) relating to the Offering, which
includes the pricing and other information omitted from the Canadian Preliminary Prospectus, to be dated the date hereof and filed with
the Canadian Securities Commissions (as defined below) in accordance with the Shelf Procedures (as defined below), together with the Canadian
Final Base Shelf Prospectus, including the Documents Incorporated by Reference therein and any supplements or amendments thereto, is hereinafter
referred to as the “Canadian Final Prospectus”.
The Underwriters also understand that the Company
has prepared and filed with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to the Canada/U.S. Multi-Jurisdictional
Disclosure System adopted by the SEC (the “MJDS”), a registration statement on Form F-10 (File No. 333-269481)
covering the public offering and sale of the securities qualified under Applicable Securities Laws (as defined below) by the Canadian
Final Base Shelf Prospectus, including the Offered Securities, under the U.S. Securities Act (as hereinafter defined) (the Canadian Final
Base Shelf Prospectus, together with any Documents Incorporated by Reference therein, any supplements or amendments thereto and with such
deletions therefrom and additions or changes thereto as are permitted or required by Form F-10 and the applicable rules and
regulations of the SEC, in the form included in such Form F-10, the “U.S. Base Prospectus”), and has also prepared
and filed with the SEC an Appointment of Agent for Service of Process and Undertaking on Form F-X (the “Form F-X”)
at the time of the initial filing of the Registration Statement (as defined below). The Company has also prepared and filed with the SEC
the Canadian Preliminary Prospectus pursuant to General Instruction II.L of Form F-10, with such deletions therefrom and additions
or changes thereto as are permitted or required by Form F-10 and the applicable rules and regulations of the SEC and including
all Documents Incorporated by Reference therein (together with the U.S. Base Prospectus, the “U.S. Preliminary Prospectus”).
The Company will prepare and file with the SEC as promptly as possible, and in any event with the SEC within one Business Day following
the filing of the Canadian Final Prospectus, the Canadian Final Prospectus pursuant to General Instruction II.L of Form F-10, with
such deletions therefrom and additions or changes thereto as are permitted or required by Form F-10 and the applicable rules and
regulations of the SEC and including all Documents Incorporated by Reference therein (together with the U.S. Base Prospectus, the “U.S.
Final Prospectus”).
As used herein, “Registration Statement”
shall mean the registration statement on Form F-10, including the U.S. Base Prospectus (as hereinafter defined), each as amended
or supplemented, and the exhibits thereto and the Documents Incorporated by Reference therein, in the form in which it became effective;
“Base Prospectuses” shall mean, collectively, the Canadian Final Base Shelf Prospectus and the U.S. Base Prospectus;
“Preliminary Prospectuses” shall mean, collectively, the Canadian Preliminary Prospectus and the U.S. Preliminary Prospectus;
and “Final Prospectuses” shall mean, collectively, the Canadian Final Prospectus and the U.S. Final Prospectus. The
information, if any, included in the Canadian Prospectus Supplement that is omitted from the Canadian Final Base Shelf Prospectus for
which a Prospectus Receipt has been obtained, but that is deemed under the Shelf Procedures to be incorporated by reference into the Canadian
Final Base Shelf Prospectus as of the date of the Canadian Prospectus Supplement, is referred to herein as the “Shelf Information”.
Any reference in this Agreement to the Registration Statement, the Base Prospectuses, the Preliminary Prospectuses or the Final Prospectuses
shall be deemed to refer to and include the Documents Incorporated by Reference therein as of the date hereof. The terms “supplement,”
“amendment,” and “amend” as used herein with respect to the Registration Statement, the Base Prospectuses, the
Pricing Disclosure Package (as defined below), the Preliminary Prospectuses or the Final Prospectuses shall include all documents subsequently
filed or furnished by the Company with or to the Canadian Securities Commissions and the SEC pursuant to the U.S. Exchange Act, that are
deemed to be incorporated by reference therein.
The U.S. Preliminary Prospectus, as supplemented by the Issuer Free
Writing Prospectuses (as defined below), if any, and the information listed in Schedule “A” hereto, taken together, are hereinafter
referred to collectively as the “Pricing Disclosure Package”. For purposes of this Agreement, the “Applicable
Time” is 9:10 a.m. (Eastern) on February 19, 2025.
The Company and the Underwriters agree that (i) any
offers or sales of the Offered Securities in Canada will be conducted through the Underwriters, or one or more affiliates of the Underwriters,
duly registered in compliance with applicable Canadian Securities Laws; and (ii) any offers or sales of the Offered Securities in
the United States will be conducted through the Underwriters, or one or more affiliates of the Underwriters, duly registered as a broker-dealer
in compliance with applicable U.S. Securities Laws and the requirements of Financial Industry Regulatory Authority, Inc. (“FINRA”).
In consideration of the agreement on the part
of the Underwriters to purchase the Offered Securities and in consideration of the services rendered and to be rendered by the Underwriters
hereunder, the Company agrees to pay to the Lead Underwriter on behalf of the Underwriters, at the Closing Time (as hereinafter defined)
a cash fee equal to 5% of the aggregate gross proceeds of the Offering (the “Underwriting Fee”) the payment of such
fee to be reflected by the Underwriters making payment of the gross proceeds of the sale of the Offered Securities or any Additional Shares,
as the case may be, to the Company less the amount of the Underwriting Fee.
This Agreement shall be subject to the following
terms and conditions:
TERMS AND CONDITIONS
Where used in this Agreement
or in any amendment hereto, the following terms shall have the following meanings, respectively:
“Additional Shares” has
the meaning given to it in the fourth paragraph of this Agreement;
“affiliate” has the
meaning given to it in the Business Corporations Act (British Columbia);
“Aggregate Flow-Through Subscription
Price” means the aggregate gross proceeds from the sale and issue of the Flow-Through Shares;
“Agreement” means
the agreement resulting from the acceptance by the Company of the offer made by the Underwriters by this letter;
“Applicable Laws” means,
in relation to any person or persons, the Applicable Securities Laws and all other statutes, regulations, rules, orders, by-laws, codes,
ordinances, decrees, the terms and conditions of any grant of approval, permission, authority or licence, or any judgment, order, decision,
ruling, award, policy or guidance document, of any Governmental Authority that are applicable to such person or persons or its or their
business, undertaking, property or securities and emanate from a Governmental Authority, having jurisdiction over the person or persons
or its or their business, undertaking, property or securities;
“Applicable Securities Laws”
means the Canadian Securities Laws and the U.S. Securities Laws;
“Base Prospectuses” has
the meaning given to it in the eleventh paragraph of this Agreement;
“Business Day” means
any day, other than a Saturday or Sunday, on which banks are open for business in Vancouver, British Columbia;
“Canadian Final Base Shelf
Prospectus” has the meaning given to it in the ninth paragraph of this Agreement;
“Canadian Final Prospectus”
has the meaning given to it in the ninth paragraph of this Agreement;
“Canadian Offering Documents”
means each of the Canadian Preliminary Prospectus and the Canadian Final Prospectus, including the Documents Incorporated by Reference
and any Marketing Documents;
“Canadian Preliminary Base
Shelf Prospectus” has the meaning given to it in the ninth paragraph of this Agreement;
“Canadian Preliminary Prospectus”
has the meaning given to it in the ninth paragraph of this Agreement;
“Canadian Prospectus Supplement”
has the meaning given to it in the ninth paragraph of this Agreement;
“Canadian Securities Commissions”
means the securities regulatory authorities in each of the Qualifying Jurisdictions;
“Canadian Securities Laws”
means all securities laws of each of the Qualifying Jurisdictions and the respective rules and regulations under such laws together
with applicable published national, multilateral and local policy statements, instruments, notices, blanket orders and rulings of the
securities regulatory authorities in the Qualifying Jurisdictions;
“CDE” means an expense
of the nature described in paragraph (c.2) of the definition of “Canadian development expense” in subsection 66.2(5) of
the Income Tax Act (Canada) or that would be described in paragraph (f) of such definition if the reference therein to “paragraphs
(a) to (e)” were a reference to “paragraph (c.2)”;
“CDS” means the CDS Clearing and Depository
Services Inc.;
“Closing Date” has the meaning given to
it in Section 14;
“Closing Time” has the meaning given to
it in Section 14;
“Commission” means
the British Columbia Securities Commission;
“Commitment Amount”
means the Aggregate Flow-Through Subscription Price paid by the subscribers of the Flow-Through Shares and received by the Company by
the Closing Date for the subscription of the Flow-Through Shares;
“common shares” means
the common shares in the capital of the Company;
“Common Shares” has
the meaning given to it in the first paragraph of this Agreement;
“Company” means Skeena
Resources Limited;
“controlled”, “distribution”,
“material change”, “material fact” and “misrepresentation” have the respective meanings
given to them in the Securities Act (British Columbia), except where otherwise specified in this Agreement;
“Corporate Records” has
the meaning given to it in Section 7(12);
“CRA” means the Canada
Revenue Agency;
“Defaulting Underwriter”
has the meaning given to it in Section 22(2);
“Documents Incorporated by
Reference” means all interim and annual financial statements, management’s discussion and analysis, business acquisition
reports, management information circulars, annual information forms, material change reports, Marketing Documents and other documents
that are or are required by Applicable Securities Laws to be incorporated by reference into the Offering Documents, as applicable, but,
for greater certainty, does not include documents superseded by other documents deemed to incorporated by reference into the Canadian
Final Base Shelf Prospectus in accordance with the terms of the Canadian Final Base Shelf Prospectus nor the technical reports filed by
the Company on SEDAR+ on September 26, 2023 and December 22, 2023;
“Eligible Issuer” means
an issuer which meets the criteria and has complied with the requirements of NI 44-101 so as to be qualified to offer securities by way
of a short form prospectus;
“Encumbrance” means
any encumbrance, lien, charge, hypothec, pledge, mortgage, title retention agreement or other security interest;
“Environmental Laws”
has the meaning given in Section 7(37)(a);
“Environmental Permits”
has the meaning given in Section 7(37)(b);
“Final Prospectuses”
has the meaning given to it in the 11th paragraph of this Agreement;
“Financial Statements”
has the meaning given to it in Section 7(18);
“Flow-Through Price”
has the meaning given to it in the second paragraph of this Agreement;
“Flow-Through Shares”
has the meaning given to it in the second paragraph of this Agreement;
“Flow-Through Subscription
Agreements” means the subscription agreements for the Flow-Through Shares to be entered into by the Company and by the Underwriters
on behalf of the purchasers of Flow-Through Shares, substantially in the form attached as Schedule “B” to this Agreement;
“Follow-On Transactions”
has the meaning given to it in Section 2(6)(a);
“Governmental Authority”
means and includes, without limitation, any national, federal, provincial, state or municipal government or other political subdivision
of any of the foregoing, any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining
to government and any corporation or other entity owned or controlled (through stock or capital ownership or otherwise) by any of the
foregoing;
“Hazardous Substances”
has the meaning given to it in Section 7(37)(a);
“IFRS” has the meaning
given to it in Section 7(18);
“Indemnified Party” has
the meaning given to it in Section 9(1);
“Indemnitor” has
the meaning given to it in Section 9(1);
“Intellectual Property”
has the meaning given to in Section 7(31);
“Issuer Free Writing Prospectus”
means an “issuer free writing prospectus” as defined in Rule 433 under the U.S. Securities Act relating to the Offered
Securities that (i) is required to be filed with the SEC by the Company, (ii) is a “road show that is a written communication”
within the meaning of Rule 433(d)(8)(i) under the U.S. Securities Act whether or not required to be filed with the SEC or (iii) is
exempt from filing pursuant to Rule 433(d)(5)(i) under the U.S. Securities Act because it contains a description of the Offered
Securities or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with the SEC
or, if not required to be filed, in the form retained in the Company’s records pursuant to Rule 433(g) under the U.S.
Securities Act;
“Marketing Documents”
means the marketing materials approved in accordance with Section 3(2);
“marketing materials”
has the meaning given to it in NI 41-101;
“Material Adverse Effect”
means any event, fact, circumstance, development, change occurrence or state of affairs (i) that is materially adverse to the
business, assets (including intangible assets), affairs, operations, liabilities (contingent or otherwise), capital, properties, condition
(financial or otherwise) or results of operations of the Company whether or not arising in the ordinary course of business or (ii) that
would result in any of the Pricing Disclosure Package or the Prospectuses containing a misrepresentation or an untrue statement of a material
fact or omitting to state a material fact necessary in order to make the statements made, in light of the circumstances under which they
were made, not misleading, all within the meaning of Applicable Securities Laws;
“Material Agreements”
mean any mortgage, note, indenture, contract, agreement (written or oral), instrument, lease or other document to which the Company
is a party or by which the Company or a material portion of the assets thereof are bound which is material to the Company (on a consolidated
basis);
“Material Property” means
the Eskay Creek project located in the Iskut River Region, in the Liard Mining Division of British Columbia;
“Money Laundering Laws”
has the meaning given in Section 7(47);
“NI 43-101” means
National Instrument 43-101 – Standards of Disclosure for Mineral Projects;
“NI 44-101” means
National Instrument 44-101 – Short Form Prospectus Distributions;
“NI 44-102” means
National Instrument 44-102 – Shelf Distributions;
“NI 51-102” means
National Instrument 51-102 – Continuous Disclosure Obligations;
“NI 52-109” means
National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings;
“Offered Securities”
has the meaning given to it in the fifth paragraph of this Agreement;
“Offering” has the
meaning given to it in the fifth paragraph of this Agreement;
“Offering Documents”
means the Canadian Offering Documents and the U.S. Offering Documents;
“Offering Jurisdictions”
means the United States and the Qualifying Jurisdictions;
“Offering Price” has
the meaning given to it in the first paragraph of this Agreement;
“OMF Subscription Agreement”
means the (Direct) Subscription Agreement dated June 24, 2024 between OMF Fund IV SPV G LLC and the Company, including for greater
certainty, the notice of assignment dated December 30, 2024;
“Permits” has the meaning given to it
in Section 7(38);
“Preliminary Canadian Prospectus
Supplement” has the meaning given to it in the eleventh paragraph of this Agreement;
“Preliminary Prospectuses”
has the meaning given to it in the eighth paragraph of this Agreement;
“Prescribed Forms”
means the forms prescribed from time to time under subsection 66(12.7) of the Tax Act, filed or to be filed by the Company within the
prescribed time renouncing to the purchasers of Flow-Through Shares the Qualifying Expenditures incurred pursuant to the Flow-Through
Subscription Agreements and all parts or copies of such forms required by the CRA, when applicable, to be delivered to the purchasers
of Flow-Through Shares;
“Prospectus Amendment”
means any amendment to the Final Prospectuses;
“Prospectus Receipt”
means the receipt issued by the Commission and the Ontario Securities Commission, which is deemed to also be a receipt of the other
Canadian Securities Commissions pursuant to Multilateral Instrument 11-102 – Passport System and National Policy 11-202 –
Process for Prospectus Reviews in Multiple Jurisdictions, for the Canadian Preliminary Base Shelf Prospectus, the Canadian Final Base
Shelf Prospectus and any Prospectus Amendment, as the case may be;
“Prospectuses” means,
collectively, the Canadian Preliminary Prospectus, the Canadian Final Prospectus, the U.S. Preliminary Prospectus and the U.S. Final Prospectus;
“Purchasers” means,
collectively, each of the purchasers of the Offered Securities arranged by the Underwriters pursuant to the Offering;
“Qualifying Expenditure”
means an expense which (i) qualifies as CDE at the date it is incurred and is an expense which may be renounced by the Company pursuant
to subsection 66(12.62) of the Tax Act, with an effective date not later than the Termination Date and in respect of which, but for the
renunciation, the Company would be entitled to a deduction from income for income tax purposes; provided that the purchasers of Flow-Through
Shares (and where a purchaser of Flow-Through Shares is a partnership, each partner of the partnership) deals with the Company on an arm’s
length basis for purposes of the Tax Act;
“Qualifying Jurisdictions”
has the meaning given to it in the eighth paragraph of this Agreement;
“Report” has the
meaning given to it in Section 7(39)(a);
“Secondary Shares” has
the meaning given to it in the first paragraph of this Agreement;
“SEDAR+” means the
System for Electronic Data Analysis and Retrieval +;
“Selling Firm” has
the meaning given to it in Section 2(1);
“Shelf Procedures”
means NI 44-101 and NI 44-102;
“Subsidiary” has
the meaning ascribed thereto in the Canadian Securities Laws of the Province of British Columbia;
“Substituted Purchasers”
has the meaning given to it in the sixth paragraph of this Agreement;
“Supplementary Material”
means, collectively, any amendment to the Offering Documents and any amendment or supplemental prospectus or ancillary materials that
may be filed by or on behalf of the Company under Applicable Securities Laws relating to the Offering and/or the distribution of the Offered
Securities;
“Tax Act” means the
Income Tax Act (Canada) and the regulations thereunder, both as amended from time to time and any proposed amendments thereto announced
publicly by or on behalf of the Minister of Finance (Canada) on or prior to the date of this Agreement;
“template version” has
the meaning ascribed to such term in NI 41-101 and includes any revised template version of marketing materials as contemplated by NI
41-101;
“Termination Date” means
December 31, 2025;
“TSX” means the Toronto
Stock Exchange;
“Underwriters” has
the meaning given to it in the first paragraph of this Agreement;
“Underwriters’ Expenses”
has the meaning given to it in Section 17;
“Underwriters’ Option”
has the meaning given to it in the fourth paragraph of this Agreement;
“Underwriting Fee” has
the meaning given to it in the 14th paragraph of this Agreement;
“United States” means
the United States of America, its territories and possessions, any State of the United States and the District of Columbia;
“U.S. Affiliate” of
any Underwriter means the U.S. registered broker-dealer affiliate of such Underwriter;
“U.S. Base Prospectus”
has the meaning given to it in the tenth paragraph of this Agreement;
“U.S. Exchange Act” means
the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder;
“U.S. Final Prospectus”
has the meaning given to it in the tenth paragraph of this Agreement;
“U.S. Offering Documents”
means the Registration Statement, the U.S. Preliminary Prospectus, the U.S. Final Prospectus and the Pricing Disclosure Package;
“U.S. Preliminary Prospectus”
has the meaning given to it in the tenth paragraph of this Agreement;
“U.S. Securities Act”
means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder; and
“U.S. Securities Laws”
means all applicable securities legislation in the United States, including, without limitation, the U.S. Securities Act, the U.S. Exchange
Act, and any applicable state securities laws.
| (2) | Capitalized terms used but not defined herein have the meanings ascribed to them in the Canadian Final
Prospectus. |
| (3) | Any reference in this Agreement to a Section or Subsection shall refer to a section or subsection
of this Agreement. |
| (4) | All words and personal pronouns relating thereto shall be read and construed as the number and gender
of the party or parties referred to in each case required and the verb shall be construed as agreeing with the required word and/or pronoun. |
| (5) | Any reference in this Agreement to “$” or to “dollars” shall refer to the lawful
currency of Canada, unless otherwise specified. |
| (6) | The following are the schedules to this Agreement, which schedules are deemed to be a part hereof and
are hereby incorporated by reference herein: |
Schedule “A” — Pricing
Terms Included in the Pricing Disclosure Package
Schedule “B” — Form of
Subscription and Renunciation Agreement for Flow-Through Shares
Section 2 |
Distribution of the Offered Securities |
| (1) | Each Underwriter shall be permitted to appoint additional investment dealers or brokers (each, a “Selling
Firm”) as its agents in the Offering and each such Underwriter may determine the remuneration payable by it to such Selling
Firm. The Underwriters may offer the Offered Securities, directly and through Selling Firms or any duly registered affiliate of an Underwriter,
in the Offering Jurisdictions for sale to the public only in accordance with Applicable Securities Laws and in any jurisdiction outside
of the Offering Jurisdictions (subject to Section 6 hereof) to purchasers permitted to purchase the Offered Securities only in accordance
with Applicable Securities Laws and applicable securities laws in such jurisdiction, and upon the terms and conditions set forth in the
Offering Documents and in this Agreement. Each Underwriter shall require any Selling Firm appointed by such Underwriter to agree to the
foregoing and such Underwriter shall be severally responsible for the compliance by such Selling Firm with the provisions of this Agreement. |
| (2) | Each Underwriter, or other registered dealer or broker, will deliver to the Company a Flow-Through Subscription
Agreement in respect of the Flow-Through Shares purchased by purchasers, excluding the Underwriter, or other registered dealer or broker,
as agent for the purchasers of Flow-Through Shares. |
| (3) | Each of the Underwriters acknowledges and agrees that it has the authority to execute and deliver the
Flow-Through Subscription Agreements on behalf of the purchasers of Flow-Through Shares. The Company and the Underwriters acknowledge
and agree that, to the extent that the Underwriters purchase any of the Flow-Through Shares, any person to whom the Underwriters resell
such Flow-Through Shares will not be eligible for the tax benefits available to Canadian resident purchasers under federal and provincial
tax legislation. |
| (4) | The Underwriters shall, and shall require any Selling Firm to agree to, distribute the Offered Securities
in a manner that complies with all applicable laws and regulations in each jurisdiction into and from which they may offer to sell the
Offered Securities or distribute the Offering Documents, as applicable, in connection with the distribution of the Offered Securities
and will not, directly or indirectly, offer, sell or deliver any Offered Securities or deliver the Offering Documents, as applicable,
to any person in any jurisdiction other than in the Offering Jurisdictions, except in a manner which will not require the Company to comply
with the registration, prospectus, continuous disclosure, filing or other similar requirements under the applicable securities laws of
such other jurisdictions. |
| (5) | For purposes of this Section 2, the Underwriters shall be entitled to assume that the Offered Securities
are qualified for distribution in any Qualifying Jurisdiction where a Prospectus Receipt shall have been obtained following the filing
of the Canadian Final Prospectus, unless otherwise notified in writing by the Company. |
| (6) | Follow-On Transactions: |
| (a) | The Company understands that following the Closing Date, some or all of the Offered Securities may immediately
be sold by the purchasers to third party investors or may otherwise be engaged in a follow-on transaction (collectively, the “Follow-On
Transactions”). |
| (b) | The Underwriters acknowledge that the Company has no knowledge of the Follow-On Transactions other than
that they may or may not occur and that the Company will have no involvement or participation in any Follow-On Transactions, other than
to register any transfer of securities required as a result, and the Company makes no representation or warranty with respect to the tax
effect any Follow-On Transaction may have on the status of the Offered Securities as “flow-through shares” for the purposes
of the Tax Act. |
| (c) | The Underwriters do not act, and will not purport to act, as agent or representative of the Company in
connection with any Follow-On Transaction and services or activities, if any, performed by the Underwriters in connection with any Follow-On
Transaction are excluded from this Agreement. The consideration payable to the Underwriters hereunder is for the Underwriter’s services
in respect of the Offering only. The parties further acknowledge that the Company is not entitled, and will not become entitled, to receive
any consideration in respect of any Follow-On Transaction that might occur. |
| (d) | The Company shall not be liable or responsible for any breach of any covenant, representation given in
this Agreement if the Flow-Through Shares are “prescribed shares” within the meaning of section 6202.1 of the regulations
to the Tax Act as a result of the Follow-On Transactions or any other action taken by purchasers which cause the Flow-Through Shares to
be or become “prescribed shares” within the meaning of section 6202.1 of the regulations to the Tax Act. |
| (7) | The Lead Underwriter shall promptly notify the Company when, in its opinion, the distribution of the Offered
Securities has ceased and will provide to the Company, as soon as practicable thereafter, a breakdown of the number of Offered Securities
distributed in each of the Offering Jurisdictions where such breakdown is required for the purpose of calculating fees payable to the
Canadian Securities Commissions and, as applicable, in the United States. |
| (8) | The Underwriters shall not, in connection with the services provided hereunder, make any representations
or warranties with respect to the Company or its securities, other than as set forth in the Offering Documents or in any Issuer Free Writing
Prospectus. |
| (9) | Notwithstanding the foregoing provisions of this Section 2, no Underwriter will be liable to the
Company under this Section 2 with respect to a default by another Underwriter or another Underwriter’s duly registered broker-dealer
affiliate in the United States or any Selling Firm, as the case may be. |
| (10) | The Underwriters acknowledge that the Company is not taking any steps to qualify the Offered Securities
for distribution or register the Offered Securities or the distribution thereof with any securities authority outside of the Offering
Jurisdictions. |
Section 3 |
Preparation of Prospectus; Marketing Materials; Due Diligence |
| (1) | During the period of the distribution of the Offered Securities, the Company shall cooperate in all reasonable
respects with the Underwriters to allow and assist the Underwriters to participate fully in the preparation of, and allow the Underwriters
to approve (acting reasonably) the form and content of, the Offering Documents and any Issuer Free Writing Prospectus and shall allow
the Underwriters to conduct all “due diligence” investigations which the Underwriters may reasonably require to fulfil the
Underwriters’ obligations under Applicable Securities Laws as underwriters and, in the case of the Supplementary Material, to enable
the Underwriters responsibly to execute any certificate required to be executed by the Underwriters. |
| (2) | Without limiting the generality of clause (1) above, during the distribution of the Offered Securities: |
| (a) | the Company shall prepare, in consultation with the Lead Underwriter, and shall approve in writing, prior
to the time that any such marketing materials are provided to potential Purchasers, a template version of any marketing materials reasonably
requested to be provided by the Underwriters to any such potential Purchasers, and such marketing materials shall comply with Applicable
Securities Laws and shall be acceptable in form and substance to the Underwriters and their counsel, acting reasonably; |
| (b) | the Lead Underwriter shall, on behalf of the Underwriters, approve a template version of any such marketing
materials in writing prior to the time that such marketing materials are provided to potential Purchasers; |
| (c) | the Company shall file a template version of any such marketing materials on SEDAR+ as soon as reasonably
practical after such marketing materials are so approved in writing by the Company and the Lead Underwriter and in any event on or before
the day the marketing materials are first provided to any potential Purchaser, and any comparables shall be removed from the template
version in accordance with NI 44-101 prior to filing such on SEDAR+ (provided that if any such comparables are removed, the Company shall
deliver a complete template version of any such marketing materials to the Commission), and the Company shall provide a copy of such filed
template version to the Underwriters as soon as practicable following such filing; and |
| (d) | following the approvals and filings set forth in Section 3(2)(a) to (c) above, the Underwriters
may provide a limited use version of such marketing materials to potential Purchasers in accordance with Applicable Securities Laws. |
| (3) | The Company and each Underwriter, on a several basis, covenants and agrees not to provide any potential
Purchaser with any marketing materials except for marketing materials which have been approved as contemplated in Section 3(2). |
Section 4 |
Material Changes |
| (1) | During the period from the date of this Agreement to the completion of the distribution of the Offered
Securities, the Company covenants and agrees with the Underwriters that it shall promptly notify the Underwriters in writing of: |
| (a) | any material change (actual, anticipated, contemplated or threatened) in or relating to the business,
affairs, operations, assets, liabilities (contingent or otherwise), capital or ownership of the Company; |
| (b) | any material fact which has arisen or been discovered and would have been required to have been stated
in any of the Offering Documents or any Issuer Free Writing Prospectus had the fact arisen or been discovered on or prior to the date
of such document; |
| (c) | any change in any material fact (which for purposes of this Agreement shall be deemed to include the disclosure
of any previously undisclosed material fact) contained in the Canadian Offering Documents, as they exist immediately prior to such change,
which fact or change is, or may reasonably be expected to be, of such a nature as to render any statement in such Canadian Offering Documents,
as they exist taken together in their entirety immediately prior to such change, misleading or untrue in any material respect or which
would result in the Canadian Offering Documents, as they exist immediately prior to such change, containing a misrepresentation or which
would result in the Canadian Offering Documents, as they exist immediately prior to such change, not complying with the laws of any Qualifying
Jurisdiction in which the Offered Securities are to be offered for sale or which change would reasonably be expected to have a significant
effect on the market price or value of any securities of the Company; or |
| (d) | the occurrence of any event as a result of which (i) the Registration Statement, as amended immediately
prior to such occurrence, would include any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein not misleading, or (ii) the Prospectuses, the Pricing Disclosure Package
or any Issuer Free Writing Prospectus, in each case as then amended or supplemented (in the case of the Pricing Disclosure Package, as
of the Applicable Time), would include any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances in which they are made, not misleading. |
| (2) | The Underwriters agree, and will require each Selling Firm to agree, to cease the distribution of the
Offered Securities upon the Underwriters receiving written notification of any change or material fact with respect to any Offering Document
contemplated by this Section 4 and to not recommence the distribution of the Offered Securities until Supplementary Materials disclosing
such change are filed in such Offering Jurisdiction. |
| (3) | The Company shall promptly comply with all applicable filing and other requirements under Applicable Securities
Laws whether as a result of such change, material fact or otherwise; provided that the Company shall not file any Supplementary Material
or other document without first providing the Underwriters with a copy of such Supplementary Material or other document and consulting
with the Underwriters with respect to the form and content thereof. |
| (4) | If during the distribution of the Offered Securities there is any change in any Applicable Securities
Laws, which results in a requirement to file a Prospectus Amendment, the Company shall, subject to the proviso in clause (2) above,
make any such filing under Applicable Securities Laws as soon as possible. |
| (5) | The Company shall in good faith discuss with the Underwriters any fact or change in circumstances (actual,
anticipated, contemplated or threatened, financial or otherwise) which is of such a nature that there is reasonable doubt whether written
notice need be given under this Section 4. |
Section 5 |
Deliveries to the Underwriters |
| (1) | The Company shall deliver or cause to be delivered to the Underwriters, forthwith: |
| (a) | copies of the Canadian Final Prospectus duly signed by the Company as required by the laws of all of the
Qualifying Jurisdictions and any Marketing Documents; |
| (b) | copies of the Registration Statement, signed as required by the U.S. Securities Act and any documents
included as exhibits to any such registration statement; |
| (c) | copies of any Prospectus Amendment required to be filed under Section 4 hereof duly signed as required
by the laws of all of the Qualifying Jurisdictions; |
| (d) | any amendments or supplements to the Registration Statement or the U.S. Final Prospectus required to be
filed under Section 4 hereof, signed as required by the U.S. Securities Act and any documents included as exhibits to the Registration
Statement; |
|
(e) |
provided, that with respect to (i) clauses (a) and (c) of this Section 5(1) if the documents are publicly available on SEDAR+, they shall be deemed to have been delivered to the Underwriters as required by this Section 5(1); and (ii) clauses (b) and (d) of this Section 5(1), if the documents are available on the SEC’s Electronic Data Gathering, Analysis, and Retrieval system, they shall be deemed to have been delivered to the Underwriters as required by this Section 5(1); and |
|
|
|
|
(f) |
further provided that delivery of the Canadian Final Prospectus, including
any amendments or supplements thereto, will be satisfied in accordance with the “access equals delivery” provisions contained
in Part 6A of NI 44-102 and the Underwriters and the Company shall satisfy any request for electronic or paper copies of such documents
in accordance with the requirements of NI 44-102, without charge. |
| (2) | The Company shall as soon as practicable cause to be delivered to the Underwriters in such cities in the
Offering Jurisdictions as they may reasonably request, without charge, such numbers of commercial copies of the Final Prospectuses, excluding
the Documents Incorporated by Reference, as the Underwriters shall reasonably require. The Company shall similarly cause to be delivered
to the Underwriters commercial copies of any Supplementary Material, excluding in each case the Documents Incorporated by Reference. The
Company agrees that such deliveries with respect to the Final Prospectuses, any Marketing Documents and any Supplementary Material shall
be effected as soon as possible and, in any event, in Vancouver and Toronto by 12:00 pm (Toronto time) on the Business Day following filing
of the Final Prospectuses or Prospectus Amendment, as the case may be, and in all other cities by 12:00 pm (Toronto time) on the second
Business Day following filing of the Final Prospectuses or Prospectus Amendment, as the case may be, provided that the Underwriters have
given the Company written instructions as to the number of copies required and the places to which such copies are to be delivered not
less than 24 hours prior to the time requested for delivery. Such delivery shall also confirm that the Company consents to the use by
the Underwriters and Selling Firms of the Offering Documents in connection with the distribution of the Offered Securities in compliance
with the provisions of this Agreement. |
| (3) | By the act of having delivered the Offering Documents to the Underwriters, (or in the case of the Pricing
Disclosure Package, having conveyed such information to prospective investors), the Company shall have represented and warranted to the
Underwriters that all information and statements (except information and statements relating solely to the Underwriters and expressly
provided by them in writing solely for inclusion therein) contained in such documents, at the respective dates of initial delivery thereof
(or as of the Applicable Time in the case of the Pricing Disclosure Package), comply in all material respects with the Applicable Securities
Laws and are true and correct in all material respects, and that such documents, at such dates, contain no misrepresentation or omit to
state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading and constitute full, true and plain disclosure of all material facts relating to the Company and the Offering
as required by the Applicable Securities Laws. |
| (4) | The Company shall also deliver or cause to be delivered to the Underwriters, concurrently with the execution
of this Agreement, a “long form” comfort letter from KPMG LLP, in form and substance satisfactory to the Underwriters, acting
reasonably, addressed to the Underwriters and the directors of the Company, with respect to certain financial and accounting information
relating to the Company and affiliates contained in the Offering Documents, which letters shall be in addition to the auditor’s
reports incorporated by reference in the Prospectuses. |
Section 6 |
Regulatory Approvals |
The Company will make all
necessary filings, use commercially reasonable efforts to obtain all necessary consents and approvals (if any) and pay all filing fees
required to be paid in connection with the transactions contemplated by this Agreement. The Company will use commercially reasonable efforts
to qualify the Offered Securities for offering and sale under the Applicable Securities Laws of the Offering Jurisdictions and in such
other jurisdictions as the Underwriters may designate and maintain such qualifications in effect for so long as required for the distribution
of the Offered Securities; provided, however, that (i) the Company shall not be obligated to make any material filing, file any prospectus,
registration statement or similar document, consent to service of process, or qualify as a foreign corporation or as a dealer in securities
in any of such other jurisdictions, or subject itself to taxation in respect of doing business in any of such other jurisdictions in which
it is not otherwise so subject, or become subject to any additional periodic reporting or continuous disclosure obligations in such other
jurisdictions, and (ii) the Underwriters and the Selling Firms shall comply with the applicable laws in any such designated jurisdiction
in making offers and sales of Offered Securities therein.
Section 7 |
Representations and Warranties of the Company |
The Company represents and
warrants to each of the Underwriters and acknowledges that the Underwriters are relying on such representations and warranties in entering
into this Agreement. The representations and warranties of the Company contained in this Agreement shall be true as of the date hereof,
the Closing Time.
| (1) | Effectiveness of the Registration Statement. The Registration Statement has become effective
pursuant to Rule 467(a) under the U.S. Securities Act; no stop order suspending the effectiveness of the Registration Statement
is in effect, and no proceedings for such purpose are pending before or, to the Company’s knowledge, threatened by the SEC. |
| (2) | No Material Misstatements or Omissions. (i) The Registration Statement, when it became
effective, did not contain and, as amended or supplemented, if applicable, will not contain, as of the date of such amendment or supplement,
any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading, (ii) the U.S. Preliminary Prospectus and the Registration Statement complied, as of the time of filing thereof,
and the U.S. Final Prospectus, as amended or supplemented, if applicable, will comply in all material respects with the U.S. Securities
Act and the applicable rules and regulations of the SEC thereunder, (iii) the Pricing Disclosure Package does not, and at the
time of each sale of the Offered Securities when the U.S. Final Prospectus is not yet available to prospective purchasers and at the Closing
Date, the Pricing Disclosure Package, as then amended or supplemented by the Company, if applicable, will not, contain any untrue statement
of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading, (iv) each broadly available road show, if any, when considered together with the Pricing Disclosure
Package, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading, and (v) as of its date and as of the Closing Date,
the U.S. Preliminary Prospectus did not contain, and the U.S. Final Prospectus, as amended or supplemented, if applicable, will not contain
any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, except that the representations and warranties set forth in this paragraph do
not apply to statements or omissions in the Registration Statement, the Pricing Disclosure Package or the Prospectuses based upon information
relating to any Underwriter furnished to the Company in writing by such Underwriter through you expressly for use therein. The Form F-X
conforms in all material respects with the requirements of the U.S. Securities Act and the rules and regulations of the SEC under
the U.S. Securities Act. |
| (3) | Compliance with Canadian Laws and Regulations. No cease trade order preventing or suspending
the use of the Canadian Final Prospectus or preventing the distribution of the Offered Securities has been issued and no proceeding for
that purpose has been initiated or, to the knowledge of the Company, threatened, by any of the Canadian Securities Commissions; as of
their respective dates and upon filing with the Canadian Securities Commissions, the Canadian Preliminary Prospectus complied and the
Canadian Final Prospectus complies in all material respects with all applicable Canadian Securities Laws; each of the Canadian Securities
Commissions in the Qualifying Jurisdictions has issued or is deemed to have issued receipts for the Canadian Preliminary Base Shelf Prospectus
and the Canadian Final Base Shelf Prospectus. The aggregate amount of all securities issued pursuant to the Canadian Final Base Shelf
Prospectus does not and, upon completion of the Offering, will not exceed $200,000,000 being the maximum allowable amount thereunder.
On the Closing Date (i) the Canadian Preliminary Prospectus complied, and the Canadian Final Prospectus will comply, in all material
respects with the Canadian Securities Laws, and (ii) the Canadian Preliminary Prospectus and the Canadian Final Prospectus or any
amendment or supplement thereto constituted at the respective dates thereof, and will constitute at the Closing Date full, true and plain
disclosure of all material facts relating to the Offered Securities, that is required to be in the Canadian Preliminary Prospectus or
the Canadian Final Prospectus, as applicable, and did not at the respective dates thereof, and will not at the Closing Date contain a
misrepresentation or an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading. To its knowledge, the Company
is not a “related issuer” or “connected issuer” (as those terms are defined in National Instrument 33-105 –
Underwriting Conflicts of the Canadian Securities Administrators) of any of the Underwriters. |
| (4) | Reporting Issuer and TSX Status. The Company is a “reporting issuer” in the
Qualifying Jurisdictions. Other than as disclosed in writing to the Underwriters, the Company is in compliance in all material respects
with the by-laws, rules and regulations of the TSX and the New York Stock Exchange (the “NYSE”). |
| (5) | Eligible Issuer. The Company is an Eligible Issuer. |
| (6) | Issuer Free Writing Prospectuses. The Company is not an “ineligible issuer”
in connection with the Offering pursuant to Rules 164, 405 and 433 under the U.S. Securities Act. Any free writing prospectus that
the Company is required to file pursuant to Rule 433(d) under the U.S. Securities Act has been, or will be, filed with the SEC
in accordance with the requirements of the U.S. Securities Act and the applicable rules and regulations of the SEC thereunder. Each
free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the U.S. Securities
Act or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects with
the requirements of the U.S. Securities Act and the applicable rules and regulations of the SEC thereunder. Except for the Issuer
Free Writing Prospectuses, if any, identified in Schedule “A” hereto, and electronic road shows, if any, each furnished to
you before first use, the Company has not prepared, used or referred to, and will not, without your prior consent, prepare, use or refer
to, any free writing prospectus. |
| (7) | Incorporated Documents. The Documents Incorporated by Reference in the Offering Documents,
when they were filed with the Canadian Securities Commissions, conformed in all material respects to the requirements of the Canadian
Securities Laws; and any further Documents Incorporated by Reference in the Canadian Offering Documents prior to the completion of the
distribution of the Offered Securities, when such documents are so filed, will conform in all material respects to the applicable requirements
of Canadian Securities Laws and will not contain a misrepresentation or an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. Each document, if any, filed or to be filed pursuant to the U.S. Exchange Act and incorporated by reference in the
Pricing Disclosure Package or the U.S. Final Prospectus complied or will comply when so filed in all material respects with the U.S. Exchange
Act, and did not or will not when so filed, contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading. |
| (8) | No Conflicts. Neither the execution of this Agreement, nor the issuance, offering or sale
of the Offered Securities, nor the consummation of any of the transactions contemplated herein and therein, nor the compliance by the
Company with the terms and provisions hereof and thereof will conflict with, or will result in a breach of, any of the terms and provisions
of, or has constituted or will constitute a default under, or has resulted in or will result in the creation or imposition of any lien,
charge or encumbrance upon any property or assets of the Company pursuant to the terms of any agreements, contracts, arrangements or understandings
(written or oral) to which the Company may be bound or to which any of the property or assets of the Company is subject, except (i) such
conflicts, breaches or defaults as may have been waived, and (ii) such conflicts, breaches and defaults that would not reasonably
be expected to have a Material Adverse Effect (as defined below); nor will such action result (x) in any violation of the provisions
of the organizational or governing documents of the Company, or (y) in any violation of the provisions of any statute or any order,
rule or regulation applicable to the Company or of any Governmental Authority having jurisdiction over the Company, except such violations
that would not reasonably be expected to have a Material Adverse Effect, either individually or in the aggregate. |
| (9) | Offered Securities. All of the Offered Securities will be, at the Closing Time, duly and
validly authorized and issued and will be fully paid and non-assessable common shares of the Company, and none of such Offered Securities
of the Company will have been issued in violation of the pre-emptive or similar rights of any securityholder of the Company or of any
other person. |
| (10) | Organization. The Company is, and will be, as of the Closing Date, duly organized, validly
existing as a corporation and in good standing under the laws of its jurisdiction of incorporation. The Company is, and will be, as of
the Closing Date, duly licensed or qualified as a foreign corporation for transaction of business and in good standing under the laws
of each other jurisdiction in which its ownership or lease of property or the conduct of its businesses requires such license or qualification,
and has all corporate power and authority necessary to own or hold its properties and to conduct its businesses as described in the Pricing
Disclosure Package and the Prospectuses, except where the failure to be so qualified or in good standing or have such power or authority
would not, individually or in the aggregate, have a Material Adverse Effect. |
| (11) | No Subsidiaries. Except as disclosed in the Pricing Disclosure Package and the Prospectuses
(or in any Document Incorporated by Reference therein), the Company has no material Subsidiaries. |
| (12) | Minute Books. All existing minute books of the Company, including all existing records of
all meetings and actions of the board of directors (including, all board committees) from January 1, 2023 until the date hereof (collectively,
the “Corporate Records”) have been made available to the Underwriters and their counsel, and all such Corporate Records
are complete in all material respects. There are no material transactions, agreements or other actions of the Company that are required
to be recorded in the Corporate Records that are not properly approved and/or recorded in the Corporate Records. All required filings
have been made with the appropriate Governmental Authorities in the province of British Columbia in a timely fashion under the Business
Corporations Act (British Columbia). |
| (13) | No Violation or Default. The Company is not (i) in violation of its articles or similar
organizational documents in any material respect; (ii) in violation or default, and no event has occurred that, with notice or lapse
of time or both, would constitute such a violation or default, in the due performance or observance of any term, covenant or condition
contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company is a party or
by which the Company is bound or to which any of the property or assets of the Company is subject; or (iii) in violation of any Applicable
Law, except in the case of each of clauses (ii) and (iii) above, for any such violation or default that would not, individually
or in the aggregate, have a Material Adverse Effect. To the Company’s knowledge, no other party under any material agreements, contracts,
arrangements or understandings (written or oral) to which it is a party is in violation or default in any respect thereunder where such
violation or default would have a Material Adverse Effect. |
| (14) | Enforceability of Agreements. All Material Agreements are legal, valid and binding obligations
of the Company enforceable in accordance with their respective terms, except to the extent that (i) enforceability may be limited
by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally and by general equitable
principles, and (ii) the indemnification provisions of certain agreements may be limited by Applicable Law or public policy considerations
in respect thereof, and except for any other potentially unenforceable term that, individually or in the aggregate, would not reasonably
be expected to be material to the Company. |
| (15) | Authorization; Enforceability. The Company has full corporate power and authority to enter
into this Agreement and perform the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered
by the Company and constitutes a legal, valid and binding agreement of the Company enforceable in accordance with its terms, except to
the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’
rights generally and by general equitable principles. |
| (16) | No Material Adverse Effect. Subsequent to September 30, 2024, there has not been any
Material Adverse Effect and there has been no event or occurrence that would reasonably be expected to result in a Material Adverse Effect
except as disclosed in the Pricing Disclosure Package and the Prospectuses. |
| (17) | Filings. The Company has filed all documents or information required to be filed by it under
Applicable Securities Laws and the rules, regulations and policies of the TSX and the NYSE, except where the failure to file such documents
or information will not have a Material Adverse Effect, either individually or in the aggregate; the Company has not filed any confidential
material change report that at the date hereof remains confidential. |
| (18) | Financial Information. The audited financial statements of the Company as at December 31,
2023 and December 31, 2022, together with the related notes and schedules (the “Financial Statements”), present
fairly, in all material respects, the consolidated financial position of the Company as of the dates indicated and the consolidated statements
of comprehensive income, shareholders’ equity and cash flows of the Company for the periods specified. Such Financial Statements
conform in all material respects with International Financial Reporting Standards as issued by the International Accounting Standards
Board (“IFRS”), applied on a consistent basis during the periods involved. The Company does not have any liabilities
or material obligations, whether contingent or otherwise, of the type required to be reflected on a balance sheet prepared in accordance
with IFRS, except for liabilities or obligations: (i) that occurred in the ordinary course of business, (ii) reflected in or
reserved against in the Financial Statements, or (iii) reflected in the Pricing Disclosure Package and the Prospectuses. |
| (19) | Independent Accountants. KPMG LLP, who have delivered their report with respect to the audited
Financial Statements for 2023 and 2022 (as defined above and which term as used in this Agreement includes the related notes thereto),
are independent public, certified public or chartered public accountants as required by applicable Canadian Securities Laws and are an
independent registered public accounting firm within the meaning of the U.S. Securities Act and the Public Company Accounting Oversight
Board (United States). |
| (20) | Disclosure Controls. The Company maintains disclosure controls and procedures (as such term
is defined in Rule 13a-15(e) under the U.S. Exchange Act) that comply with the requirements of the U.S. Exchange Act; such disclosure
controls and procedures have been designed to ensure that information required to be disclosed by the Company in the reports that it files
or submits under the U.S. Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s
rules and forms. Management of the Company assessed its disclosure controls as of December 31, 2023 and concluded such disclosure
controls and procedures were effective as of December 31, 2023; |
| (21) | Capitalization. The issued and outstanding Common Shares have been validly issued, are fully
paid and non-assessable and are not subject to any pre-emptive rights, rights of first refusal or similar rights. The Company has an authorized,
issued and outstanding capitalization as set forth in or included or incorporated by reference in the Pricing Disclosure Package and the
Prospectuses as of the dates referred to therein (other than pursuant to outstanding rights or obligations under securities or contractual
rights or the grant of additional options, restricted share units (“RSUs”), performance share units (“PSUs”)
or deferred share units (“DSUs”, and collectively with the RSUs and the PSUs, the “Share Units”)
under the Company’s existing omnibus equity incentive plan, or changes in the number of outstanding Common Shares of the Company
due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Shares, including
without limitation the exercise of stock options, exercise of warrants, vesting of Share Units and, in each case outstanding on the date
hereof) and such authorized capital stock conforms in all material respects to the description thereof set forth in, or included or incorporated
by reference in the Pricing Disclosure Package and the Prospectuses. The description of the securities of the Company in the Pricing Disclosure
Package and the Prospectuses is complete and accurate in all material respects. Except as disclosed in or contemplated by or included
or incorporated by reference in the Pricing Disclosure Package and the Prospectuses, the Company has not issued any options to purchase,
or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or
commitments to issue or sell, any Common Shares or other securities. Except as disclosed in or contemplated by or included or incorporated
by reference in the Pricing Disclosure Package, the Prospectuses or the OMF Subscription Agreement, no person has any agreement
or option or right or privilege (whether by law, pre-emptive or contractual) issued or capable of becoming an agreement for: (i) the
purchase, subscription or issuance of any unissued shares, securities or warrants of the Company; or (ii) the repurchase by or on
behalf of the Company of any issued and outstanding securities of the Company. |
| (22) | Share Capital of the Company. The authorized capital of the Company consists of an unlimited
number of Common Shares of which, as of the date hereof, 108,806,071 Common Shares were outstanding as fully paid and non-assessable shares
in the capital of the Company. |
| (23) | Voting or Control Agreements. Except pursuant to the OMF Subscription Agreement, to the
knowledge of the Company, no agreement is in force or effect which in any manner affects the voting or control of any of the securities
of the Company. |
| (24) | Restrictions on Business. The Company is not a party to or bound or affected by any commitment,
agreement or document containing any covenant which expressly limits the freedom of the Company to compete in any line of business, transfer
or move any of its assets or operations which materially and adversely affects, or could reasonably be expected to materially and adversely
affect, the business practices, operations or condition of the Company. |
| (25) | No Applicable Registration or Other Similar Rights. Except pursuant to the OMF Subscription
Agreement, there are no persons with registration or other similar rights to have any equity or debt securities registered or qualified
for sale under the Pricing Disclosure Package and the Prospectuses or included in the Offering contemplated by this Agreement who have
not waived such rights in writing (including electronically) prior to the execution of this Agreement. |
| (26) | No Consents Required. No consent, approval, authorization, order, registration or qualification
of or with Governmental Authority or stock exchange is required for the execution, delivery and performance by the Company of this Agreement,
the issuance and sale by the Company of the Offered Securities, except for (i) the qualification of the Offered Securities for distribution
in Canada by the filing of the Canadian Offering Documents and receipt of the relevant Prospectus Receipts therefore; and (ii) the approval
of the TSX and the NYSE, and except as such as have been obtained or may be required by the securities or Blue Sky laws of the various
states in connection with the offer and sale of the Offered Securities and the filing of the Canadian Final Prospectus. |
| (27) | Transfer Agent. Computershare Investor Services Inc. has been duly appointed as registrar
and transfer agent for the Common Shares and Computershare Trust Company, N.A. has been duly appointed as U.S. co-registrar and co-transfer
agent for the Common Shares. |
| (28) | No Litigation. Except as disclosed in or incorporated by reference in the Pricing Disclosure
Package and the Prospectuses, there are no legal, governmental or regulatory actions, suits or proceedings pending, nor, to the Company’s
knowledge, any legal, governmental or regulatory audits or investigations, to which the Company is a party or to which any property of
the Company is subject that, individually or in the aggregate, if determined adversely to the Company, could reasonably be expected to
have a Material Adverse Effect or materially and adversely affect the ability of the Company to perform its obligations under this Agreement.
Except as disclosed in or incorporated by reference in the Pricing Disclosure Package and the Prospectuses, to the Company’s knowledge,
no such actions, suits, proceedings, audits or investigations are threatened or contemplated by any Governmental Authority or threatened
by others. |
| (29) | Material Agreements. Neither the Company nor, to the Company’s knowledge, any other
party is in material default in the observance or performance of any material term or material obligation to be performed by any of them
under any Material Agreement and no event has occurred which with notice or lapse of time or both would constitute such a default, in
any such case which default or event would reasonably be expected to have a Material Adverse Effect on the Company. |
| (30) | No Acquisition or Disposition. The Company has not completed any “significant acquisition”,
“significant disposition” nor is it proposing any “probable acquisitions” (as such terms are defined in NI 51-102)
that would require the inclusion of any additional financial statements or pro forma financial statements in the Offering Documents pursuant
to Applicable Securities Laws. |
| (31) | Intellectual Property Rights. Except as disclosed in or incorporated by reference in the
Pricing Disclosure Package and the Prospectuses, the Company owns, possesses, licenses or has other rights to use all foreign and domestic
patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions,
trade secrets, technology, Internet domain names, know-how and other intellectual property (collectively, the “Intellectual
Property”), necessary for the conduct of their respective businesses as now conducted except to the extent that the failure
to own, possess, license or otherwise hold adequate rights to use such Intellectual Property would not, individually or in the aggregate,
have a Material Adverse Effect. |
| (32) | No Material Defaults. The Company has not defaulted on any installment on indebtedness for
borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would have a Material
Adverse Effect. |
| (33) | Title to Real and Personal Property. |
| (a) | The Company is the beneficial owner of the material properties and assets relating to the Material Property,
free of all material Encumbrances whatsoever, other than such Encumbrances disclosed in the Pricing Disclosure Package and the Prospectuses. |
| (b) | Any and all agreements pursuant to which the Company holds or will hold any such interest in its material
property or assets relating to the Material Property are in good standing in all material respects according to their terms, and the properties
are in good standing under the applicable statutes and regulations of the jurisdictions in which they are situated except, in any case,
where it would not result in a Material Adverse Effect. |
| (a) | The Material Property is the only mineral property currently material to the Company. |
| (b) | The Company holds either mining leases, mining claims, mineral claims, surface leases or exploration permits
recognized in the jurisdiction in which the Material Property is located in respect of the ore bodies and minerals located in the Material
Property as described in the Pricing Disclosure Package and the Prospectuses under valid, subsisting and enforceable title documents or
other recognized and enforceable agreements or instruments, sufficient to permit the Company to explore the minerals relating thereto. |
| (c) | All mining leases, mineral claims and surface leases relating to the Material Property in which the Company
has an interest or right are valid and in good standing in accordance with all Applicable Laws. |
| (d) | Except as disclosed in the Pricing Disclosure Package and the Prospectuses, the Company has all necessary
surface rights, access rights and other necessary rights and interest relating to the Material Property granting the right and ability,
as applicable, to explore and access minerals, ore and metals for development purposes as described in the Pricing Disclosure Package
and the Prospectuses, subject to the Company’s ability to maintain the Permits (as defined below), with only such exceptions as
do not materially interfere with the use made by the Company of the rights or interests in the Material Property. |
| (e) | Except as disclosed in the Pricing Disclosure Package and the Prospectuses, all assessments or other work
required to be performed in relation to the material mineral claims of the Company in order to maintain their respective interests therein,
if any, have been performed to date. |
| (f) | Except as disclosed in the Pricing Disclosure Package and the Prospectuses, the Company does not have
any responsibility or obligation to pay any commission, royalty, license, fee or similar payment to any person with respect to the property
rights thereof, except where such fee or payment would not have a Material Adverse Effect, either individually or in the aggregate. |
| (g) | There are no expropriations or similar proceedings or any material challenges to title or ownership, actual
or threatened, of which the Company has received notice against any Material Property. |
| (35) | Aboriginal Claims. Except as set forth in the Pricing Disclosure Package and the Prospectuses,
there are no material claims or actions with respect to aboriginal or native rights against or affecting the Company or, to the best of
the knowledge of the Company, pending or threatened, including with respect to the Material Property. Other than as set forth in the Pricing
Disclosure Package and the Prospectuses, the Company is not aware of any material land entitlement claims or aboriginal land claims having
been asserted or any legal actions relating to aboriginal or community issues having been instituted with respect to the such properties,
and no material dispute in respect of such properties with any local or aboriginal or native group exists or, to the knowledge of the
Company, is threatened or imminent with respect thereto or activities thereon. |
| (36) | Exploration Activities. All mineral exploration activities by the Company on the properties
of the Company have been conducted in all material respects in accordance with good mining and engineering practices and all applicable
workers’ compensation and health and safety and workplace laws, regulations and policies have been duly complied with except where
the failure to so conduct operations could not reasonably be expected to have a Material Adverse Effect. |
| (37) | Environmental Laws. Except as set forth in the Pricing Disclosure Package and the Prospectuses: |
| (a) | to the best of the knowledge of the Company, the Company is in compliance in all material respects with
all applicable federal, provincial, municipal and local laws, statutes, ordinances, bylaws and regulations and orders, directives and
decisions rendered by any ministry, department or administrative or regulatory agency (the “Environmental Laws”) applicable
to the Company and relating to the protection of the environment, occupational health and safety or the processing, use, treatment, storage,
disposal, discharge, transport or handling of any pollutants, contaminants, chemicals or industrial, toxic or hazardous wastes or substance
(the “Hazardous Substances”); |
| (b) | the Company has obtained all material licenses, permits, approvals, consents, certificates, registrations
and other authorizations under all applicable Environmental Laws (the “Environmental Permits”) necessary as at the
date hereof for the operation of the business currently carried on by the Company and each Environmental Permit is valid, subsisting and
in good standing and the Company is not in material default or breach of any Environmental Permit, and no proceeding is pending or, to
the knowledge of the Company, threatened, to revoke or limit any Environmental Permit; |
| (c) | the Company has not received any notice of, or been prosecuted for an offence alleging, non-compliance
with any Environmental Law that would have a Material Adverse Effect, and the Company (including, if applicable, any predecessor companies)
has not settled any allegation of non-compliance that would have a Material Adverse Effect short of prosecution. There are no orders or
directions relating to environmental matters requiring any material work, repairs, construction or capital expenditures to be made with
respect to any of the assets of the Company, nor to the knowledge of the Company, have any such orders or directions been threatened; |
| (d) | the Company has not received any notice wherein it is alleged or stated that the Company is potentially
responsible for a federal, provincial, municipal or local clean-up site or corrective action under any Environmental Laws other than in
the ordinary course of business; |
| (e) | the Company has not received any request for information in connection with any federal, municipal or
local inquiries as to disposal sites and, to the best of the knowledge of the Company, there are no environmental audits, evaluations,
assessments, studies or tests being conducted by any federal, municipal or local except for ongoing audits, evaluations, assessments,
studies or tests being conducted in the ordinary course; and |
| (f) | the Company is in compliance in all material respects with all applicable workers’ compensation
and health and safety and workplace laws, regulations and policies. |
| (38) | Permits. Except as disclosed in the Pricing Disclosure Package and the Prospectuses: |
| (a) | the Company has obtained or identified all the material permits, certificates, and approvals (collectively,
the “Permits”) which are required for its current operations on the Material Property, which Permits include but are
not limited to environmental assessment certificates, water licenses, land tenures, rezoning or zoning variances and other necessary local,
provincial and federal approvals; and |
| (b) | the required Permits have either been received, applied for, or the processes to obtain such Permits have
been or will in due course be initiated by the Company. |
| (39) | NI 43-101 Technical Report. |
| (a) | the Company made available to the respective authors thereof prior to the issuance of the technical report
filed by the Company on SEDAR+ on December 22, 2023 relating to the Material Property (the “Report”), for the
purpose of preparing the Report, as applicable, all material information requested, and no such information contained any material misrepresentation
as at the relevant time the relevant information was made available; |
| (b) | the Report is current and complies in all material respects with the requirements of NI 43--101 as at
the date of such Report; |
| (c) | the Company is in compliance, in all material respects, with the provisions of NI 43-101; and |
| (d) | except as noted in the Pricing Disclosure Package and the Prospectuses, all scientific and technical information
disclosed in the Pricing Disclosure Package and the Prospectuses: (i) is based upon information prepared, reviewed and/or verified
by or under the supervision of a “qualified person” (as such term is defined in NI 43-101), (ii) has been prepared and
disclosed in accordance with Canadian industry standards set forth in NI 43--101, and (iii) was true, complete and accurate in all
material respects at the time of filing. |
| (40) | Insurance. The Company maintains insurance covering its properties, operations, personnel
and businesses that the Company reasonably deems adequate; such insurance insures against such losses and risks to an extent which is
adequate in accordance with customary industry practice to protect such persons and the business of the Company; all such insurance is
fully in force on the date hereof and will be fully in force on the Closing Date. The Company has no reason to believe that such persons
will not be able to renew such existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue their businesses at a cost that would not be reasonably expected to have a Material Adverse Effect
on the Company. |
| (a) | The Company is in compliance in all material respects with all laws respecting employment and employment
practices, terms and conditions of employment, pay equity and wages. |
| (b) | There has not been and there is not currently any labour disruption or conflict nor, to the knowledge
of the Company, is any labour disruption or conflict threatened which would reasonably be expected to have a Material Adverse Effect. |
| (c) | Each material plan for retirement, bonus, stock purchase, profit sharing, stock options, deferred compensation,
severance or termination pay, insurance, medical, hospital, dental, vision care, drug, sick leave, disability, salary continuation, legal
benefits, unemployment benefits, vacation, incentive or otherwise contributed to or required to be contributed to, by the Company for
the benefit of any current or former director, officer, employee or consultant of the Company (the “Employee Plans”)
has been maintained in material compliance with its terms and with the requirements prescribed by any and all statutes, orders, rules and
regulations that are applicable to such Employee Plan. |
| (d) | All material accruals for unpaid vacation pay, premiums for unemployment insurance, health premiums, federal
or provincial pension plan premiums, accrued wages, salaries and commissions and Employee Plan payments have been reflected in the books
and records of the Company and the Financial Statements. |
| (e) | To the knowledge of the Company, no officer, director, employee or security holder of the Company has
any cause of action or other claim whatsoever against, or owes any amount to, the Company in connection with its business except for claims
in the ordinary and normal course of the business such as for accrued vacation pay or other amounts or matters which would not be material
to the Company. |
| (42) | Related Party Transactions. Except as disclosed in the Pricing Disclosure Package and the
Prospectuses: |
| (a) | the Company does not owe any monies to or has any present loans to, or borrowed any monies from or is
otherwise indebted to, any officer, director, employee, shareholder or any person not dealing at “arm’s length” (as
such term is defined in the Tax Act) with the Company or its subsidiaries except for usual employee reimbursements and compensation paid
in the ordinary and normal course of its business; |
| (b) | except for usual employee or consulting arrangements made in the ordinary and normal course of business,
the Company is not a party to any contract, agreement or understanding with any officer, director, employee, shareholder or any other
person not dealing at arm’s length with it; and |
| (c) | except for any participation in the Offering, none of the directors, officers or employees of the Company,
any known holder of more than ten percent (10%) of any class of shares of the Company, or any known associate or affiliate of any of the
foregoing persons has had any material interest, direct or indirect, in any material transaction with the Company, or any proposed material
transaction which, as the case may be, materially affected, is material to or will materially affect the Company or its business. |
| (43) | Taxes. The Company has filed all federal, state, provincial, local and foreign tax returns
which have been required to be filed and such tax returns are correct and complete in all material respects, and has paid all taxes shown
thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where
the failure to so file or pay would not have a Material Adverse Effect. Except as otherwise disclosed in the Pricing Disclosure Package
and the Prospectuses, no tax deficiency has been determined adversely to the Company which would have, individually or in the aggregate,
a Material Adverse Effect. The Company has no knowledge of any federal, state, provincial or other governmental tax deficiency, penalty
or assessment which has been asserted or threatened in writing against it which would have a Material Adverse Effect. |
| (44) | Investment Company Act. The Company is not nor, after giving effect to the offering and
sale of the Offered Securities and the application of the proceeds thereof as described in the Pricing Disclosure Package and the Prospectuses,
as applicable, will be required to register as an “investment company” or an entity “controlled” by an “investment
company,” as such terms are defined in the Investment Company Act of 1940, as amended. |
| (45) | Finder’s Fees. The Company has not incurred any liability for any finder’s fees,
brokerage commissions or similar payments in connection with the transactions herein contemplated, except as may otherwise exist with
respect to the Underwriters pursuant to this Agreement. |
| (46) | No Improper Practices. (i) None of the Company, any of its subsidiaries or controlled
affiliates, or, to the Company’s knowledge, any of the directors, officers, agents, affiliates or representatives of the Company
or any of its subsidiaries or controlled affiliates, has, in the past five years, made any unlawful contributions to any candidate for
any political office (or failed fully to disclose any contribution in violation of Applicable Law) or taken any action in furtherance
of an offer, a contribution or other payment, or promise to pay, or authorized or approved the payment or giving of money, property, gifts
or anything else of value, directly or indirectly, to any official of, or candidate for, any federal, state, provincial, municipal, or
foreign office or other person charged with similar public or quasi-public duties, other than payments required or permitted by the laws
of the United States or Canada of any jurisdiction thereof. Without limiting the generality of the foregoing, none of the Company, its
subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries
is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the Corruption of
Foreign Public Officials Act (Canada) or the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations
thereunder (collectively the “Foreign Corruption Laws”), including, without limitation, making use of the mails or
any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of
the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any “foreign
official” (as such term is defined in the Foreign Corruption Laws) or any foreign political party or official thereof or any candidate
for foreign political office, in contravention of the Foreign Corruption Laws; and the Company and each of its subsidiaries in compliance
with the Foreign Corruption Laws and have instituted and maintain policies and procedures designed to ensure, and which are reasonably
expected to continue to ensure, continued compliance therewith. |
| (47) | Operations. To the best of the knowledge of the Company, the operations of the Company are
and have been conducted at all times in compliance with applicable financial record keeping and reporting requirements of the Proceeds
of Crime (Money Laundering) and Terrorist Financing Act (Canada), the Foreign Corruption Laws, the Bank Secrecy Act, as amended
by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act
of 2001 (USA PATRIOT Act) and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced
by any Governmental Authority (collectively, the “Money Laundering Laws”); and no action, suit or proceeding by or
before any court or Governmental Authority involving the Company or any of its subsidiaries with respect to the Money Laundering Laws
is pending or threatened. |
| (a) | Neither the Company nor any of its subsidiaries, nor any director, officer, or employee thereof, nor,
to the Company’s knowledge, any agent, affiliate or representative of the Company or any of its subsidiaries, is an individual or
entity (“Person”) that is, or is owned or controlled by a Person that is: (i) the subject of any sanctions administered
or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control, the United Nations Security Council, the European
Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”), nor (ii) located,
organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, Crimea, Cuba, Iran,
North Korea and Syria). |
| (b) | The Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: (i) to fund or facilitate any activities
or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of
Sanctions, or (ii) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating
in the offering, whether as underwriter, advisor, investor or otherwise). |
| (c) | The Company and its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and
will not knowingly engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing
or transaction is or was the subject of Sanctions. |
| (49) | U.S. Status. The Company meets the general eligibility requirements for the use of Form F-10
under the U.S. Securities Act and at the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest
time thereafter that the Company or any offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under
the U.S. Securities Act) of the Offered Securities and at the date hereof, the Company was not and is not an “ineligible issuer”,
as defined in Rule 405 under the U.S. Securities Act; |
| (50) | Due Diligence Matters. All documents and information delivered and provided by or on behalf
of the Company to the Underwriters as a part of their due diligence in connection with the Offering were complete and accurate in all
material respects. |
| (51) | TSX and NYSE Listings. The Common Shares are listed for trading on the TSX and the NYSE
under the symbol “SKE”, and the Company has taken no action designed to delist the Common Shares from the TSX or the NYSE,
nor has the Company received any notification that the Canadian Securities Commissions, the SEC, the TSX or the NYSE is contemplating
terminating such registration or listing, as applicable. Except as disclosed in the Pricing Disclosure Package and the Prospectuses, the
Company has complied in all material respects with the applicable requirements of the TSX and the NYSE for maintenance of inclusion of
the Common Shares thereon. As at the Closing Date, the Company will have obtained all necessary consents, approvals, authorizations or
orders of, or filing, notification or registration with, the TSX, the NYSE, the Canadian Securities Commissions and the SEC, where applicable,
required for the listing and trading of the Offered Securities subject only to satisfying their standard listing and maintenance requirements. |
| (52) | Qualifying Expenditures. |
| (a) | The expenses to be renounced by the Company to the purchasers of Flow-Through Shares will constitute Qualifying
Expenditures on the effective date of the renunciation and on the date incurred. The expenses to be renounced by the Company to the purchasers
of Flow-Through Shares (i) will not include any amount that has previously been renounced by the Company to any of the purchasers
of Flow-Through Shares or to any other Person; and (ii) would be deductible by the Company in computing its income for the purposes
of Part I of the Tax Act but for the renunciation to the purchasers of Flow-Through Shares. |
| (b) | The Company has no reason to believe that it will be unable to incur, on or after the Closing Date and
on or before the Termination Date or that it will be unable to renounce to the purchasers of Flow-Through Shares, effective on or before
the Termination Date, Qualifying Expenditures in an amount equal to the Commitment Amount and the Company has no reason to expect any
reduction of such amounts by virtue of subsection 66(12.73) of the Tax Act. |
| (c) | The Company is and will continue to be a “principal-business corporation” as defined in subsection
66(15) of the Tax Act until such time as all of the Qualifying Expenditures required to be renounced under this Agreement and the Flow-Through
Subscription Agreements have been incurred and validly renounced pursuant to the Tax Act. |
| (a) | Except as a result of (i) any agreement, arrangement, undertaking or understanding to which the Company
is not a party, (ii) any agreement, arrangement, undertaking or understanding in respect of a Follow-On Transaction, and (iii) any
other action taken by a purchaser which causes any Flow-Through Shares to be or become “prescribed shares” within the meaning
of section 6202.1 of the regulations to the Tax Act, upon issue the Flow-Through Shares will be “flow-through shares” as defined
in subsection 66(15) of the Tax Act and will not be “prescribed shares” within the meaning of section 6202.1 of the regulations
to the Tax Act. |
| (b) | If the Company amalgamates or otherwise merges with any one or more companies, any shares issued to or
held by the purchasers of Flow-Through Shares as a replacement for the Flow-Through Shares as a result of such amalgamation or merger
will qualify, by virtue of subsection 87(4.4) of the Tax Act, as “flow-through shares” as defined in subsection 66(15) of
the Tax Act and in particular will not be “prescribed shares” as defined in section 6202.1 of the regulations to the Tax Act. |
| (c) | The Company is not, and has never been, in default of any of its legal obligations in respect of any “flow-through
share” financings previously undertaken by the Company. |
Section 8 |
Representations, Warranties and Covenants of the Underwriters |
| (1) | Each Underwriter hereby severally, and not jointly, nor jointly and severally, represents and warrants
to the Company that: |
| (a) | it is, and will remain so, until the completion of the Offering, appropriately registered under Applicable
Securities Laws so as to permit it to lawfully fulfill its obligations hereunder; and |
| (b) | it has good and sufficient right and authority to enter into this Agreement and complete the transactions
contemplated under this Agreement on the terms and conditions set forth herein. |
| (2) | The Underwriters hereby covenant and agree with the Company to the following: |
| (a) | Compliance with Securities Laws. The Underwriters will comply with applicable securities
laws (including Applicable Securities Laws) in connection with the distribution of the Offered Securities. |
| (b) | Completion of Distribution. The Underwriters will use their commercially reasonable efforts
to complete the distribution of the Offered Securities as promptly as possible after the Closing Time. |
| (3) | The Company agrees that the Underwriters are acting severally and not jointly (or jointly and severally)
in performing their respective obligations under this Agreement and that no Underwriter shall be liable for any act, omission or conduct
by any other Underwriter or another Underwriter’s duly registered broker-dealer affiliate in the United States or any Selling Firm. |
| (4) | Distribution in Canada. No Underwriter that is a non-resident for purposes of the Tax Act
will render any services under this Agreement in Canada. |
Section 9 |
Indemnification |
| (1) | The Company (also referred to in this Section 9 as the “Indemnitor”) agrees to
indemnify and hold harmless the Underwriters, their respective affiliates and subsidiaries, and their respective directors, officers,
partners, agents, employees and shareholders and each other person, if any, controlling any of the Underwriters or their subsidiaries
or affiliates directors, officers, employees and agents of the Underwriters (hereinafter referred to as the “Personnel”
and together with the Underwriters and their respective affiliates and subsidiaries, the “Indemnified Parties” and
individually, an “Indemnified Party”), from and against any and all losses, expenses, claims (including shareholder
actions, derivative or otherwise), actions, damages and liabilities, joint or several, including without limitation the aggregate
amount paid in reasonable settlement of any actions, suits, proceedings, investigations or claims and the reasonable fees and expenses
of their counsel but excluding any loss of profits (collectively, the “Losses”) that may be suffered by, imposed
upon or asserted against an Indemnified Party as a result of, in respect of, connected with or arising out of any action, suit, proceeding,
investigation or claim that may be made or threatened by any person or in enforcing this indemnity (collectively the “Claims”)
insofar as the Claims relate to, are caused by, result from, arise out of or are based upon, directly or indirectly, the services
performed by the Underwriters in connection with the Offering, whether performed before or after the Underwriters’ execution
of the Agreement. The Indemnitor agrees to waive any right the Indemnitor may have of first requiring an Indemnified Party to proceed
against or enforce any other right, power, remedy or security or claim payment from any other person before claiming under this
indemnity. The Indemnitor also agrees that no Indemnified Party shall have any liability (whether direct or indirect, in contract
or tort or otherwise) to the Indemnitor or any person asserting Claims on behalf of or in right of the Indemnitor for or in connection
with the Offering except to the extent any Losses suffered by the Company are determined by a court of competent jurisdiction in a final
judgement that has become non-appealable to have resulted from the negligence, willful misconduct, or other fraudulent act of such Indemnified
Party. The Indemnitor will not, without the prior written consent of the Underwriters, settle, compromise, consent to the entry
of any judgment in or otherwise seek to terminate any Claim in respect of which indemnification may be sought under this indemnity
(whether or not any Indemnified Party is a party to such Claim) unless the Indemnitor has acknowledged in writing that the Indemnified
Parties are entitled to be indemnified in respect of such Claim and such settlement, compromise, consent or termination includes
an unconditional release of each Indemnified Party from any liabilities arising out of such Claim without any admission of negligence,
misconduct, liability or responsibility by or on behalf of any Indemnified Party. |
| (2) | Promptly after receiving notice of a Claim against any Indemnified Party or receipt of notice of
the commencement of any investigation which is based, directly or indirectly, upon any matter in respect of which indemnification
may be sought from the Indemnitor, the relevant Indemnified Party will notify the Indemnitor in writing of the particulars thereof,
provided that the omission so to notify the Indemnitor shall not relieve the Indemnitor of any liability which the Indemnitor may
have to any Indemnified Party, except to the extent the Company is materially prejudiced by such omission. The Indemnitor shall have
14 days after receipt of the notice to undertake, conduct and control, through counsel of their own choosing and at their own expense,
the settlement or defense of the Claim. If the Indemnitor undertakes, conducts or controls the settlement or defense of the Claim,
the relevant Indemnified Parties shall have the right to participate in the settlement or defense of the Claim. |
| (3) | The Indemnitor agrees to reimburse the Underwriters for the time spent by their personnel in connection
with any Claim at their normal per diem rates. The Indemnified Parties may retain counsel to separately represent them in the defense
of a Claim, which shall be at the Indemnitor’s expense if (i) the Indemnitor does not promptly assume the defense
of the Claim no later than 14 days after receiving actual notice of the Claim (as set forth in Section 9(2)), (ii) the
Indemnitor agrees to separate representation, or (iii) the Indemnified Parties are advised by counsel that there is an actual
or potential conflict in the Indemnitor’s and the Indemnified Parties’ respective interests or additional defenses are
available to the Indemnified Parties, which makes representation by the same counsel inappropriate. Under no circumstances will
the Company be required to pay the fees and disbursements of more than one counsel on behalf of the Indemnified Parties. |
| (4) | The indemnity provided for in this Section 9 shall not apply to the extent that a court of competent
jurisdiction in a final judgment that has become non-appealable has determined that such Losses to which the Indemnified Party
may be subject were caused primarily by the gross negligence, intentional fault or willful misconduct of the Indemnified Party. |
| (5) | If for any reason the indemnity provided for in this Section 9 is unavailable (other than in accordance
with the terms hereof) to the Underwriters or any other Indemnified Party or insufficient to hold the Underwriters or any other
Indemnified Party harmless in respect of a Claim, the Indemnitor shall, contribute to the amount paid or payable by the Underwriters
or the other Indemnified Party as a result of such Claim in such proportion as is appropriate to reflect not only the relative benefits
received by the Indemnitor on the one hand and the Underwriters or any other Indemnified Party on the other hand but also the
relative fault of the Indemnitor, the Underwriters or any other Indemnified Party as well as any relevant equitable considerations;
provided that the Indemnitor shall in any event contribute to the amount paid or payable by the Underwriters or any other Indemnified
Party as a result of such Claim any excess of such amount over the amount of the fees received by the Underwriters under the
Agreement. |
| (6) | The Indemnitor hereby constitutes the Lead Underwriter as trustee for each of the other Indemnified Parties
of the Indemnitor’s covenants under this indemnity with respect to those persons and the Lead Underwriter agrees to accept that
trust and to hold and enforce those covenants on behalf of those persons. |
| (7) | The obligations of the Indemnitor hereunder are in addition to any liabilities which the Indemnitor may
otherwise have to the Underwriters or any other Indemnified Party, shall extend upon the same terms and conditions to the Indemnified
Parties and shall be binding upon and enure to the benefit of any successors, permitted assigns, heirs and personal representatives
of the Indemnitor, the Underwriters and any other Indemnified Party. The foregoing provisions shall survive any termination of this Agreement
or the completion of the Offering. |
| (1) | In order to provide for a just and equitable contribution in circumstances in which the indemnity provided
in Section 9 would otherwise be available in accordance with its terms but is, for any reason (other than for circumstances described
in Section 9(4)), held to be unavailable to or unenforceable by the Indemnified Party or enforceable otherwise than in accordance
with its terms or is insufficient to hold the Indemnified Party harmless, the Indemnitor shall contribute to the aggregate of all claims,
expenses, costs and liabilities and all losses (other than loss of profits in connection with the distribution of the Offered Securities
and other indirect and consequential damages) of the nature contemplated in this Section 10 and suffered or incurred by the Indemnified
Parties in such proportions as is appropriate to not only reflect the relative benefits received by the Company on the one hand and the
Underwriters on the other hand from the distribution of the Offered Securities but also the relative fault of the Company on one hand
and the Indemnified Parties on the other hand in connection with the Claim or Claims which resulted in such claims, expenses, costs, damages,
liabilities or losses, as well as any other equitable considerations determined by a court of competent jurisdiction; provided that the
Company shall, in any event contribute to the amount paid or payable by the Underwriters or any other Indemnified Party as a result of
such expense, loss, clam damage or liability any excess of such amount over the amount of the fees received by the Underwriters hereunder. |
| (2) | The Underwriters’ obligations to contribute pursuant to this Section 10 are several, and not
joint, in proportion to their respective underwriting commitments as set forth opposite their respective names in Section 22 hereof. |
| (3) | In the event that the Indemnitor is held to be entitled to contribution from the Underwriters under the
provisions of any Applicable Law, the Indemnitor shall be limited to contribution in an amount not exceeding the lesser of: |
| (a) | the portion of the full amount of the loss or liability giving rise to such contribution for which the
Underwriters are responsible, as determined above; and |
| (b) | the amount of the aggregate fee actually received by the Underwriters from the Indemnitor hereunder, provided
that no individual Underwriter shall be required to contribute more than the fee actually received by such Underwriter. |
| (4) | With respect to Section 9 and this Section 10, the Company acknowledges and agrees that the
Underwriters are contracting on their own behalf and as agents for their respective affiliates and subsidiaries (including the U.S. Affiliates)
and each of their respective directors, officers, partners, employees and shareholders, and each person, if any, controlling any Underwriter
or any of its subsidiaries or affiliates and each shareholder of any Underwriter. Accordingly, the Company hereby constitutes the Underwriters
as agents for each person who is entitled to the covenants of the Company contained in Section 9 and this Section 10 and is
not a party hereto and the Underwriters agree to accept such agents and to hold in trust for and to enforce such covenants on behalf of
such persons. |
Section 11 |
Covenants of the Company |
| (1) | The Company covenants and agrees with the Underwriters that: |
| (a) | the Company will advise the Underwriters, promptly after receiving notice thereof, of the time when each
Offering Document or Issuer Free Writing Prospectus has been filed, and will provide evidence satisfactory to the Underwriters of each
such filing; |
| (b) | between the date hereof and the date of completion of the distribution of the Offered Securities, the
Company will advise the Underwriters, promptly after receiving notice or obtaining knowledge thereof, of: |
| i. | the issuance by any Canadian Securities Commission or U.S. securities regulator of any order suspending
or preventing the use of any of the Offering Documents; |
| ii. | the issuance by any Canadian Securities Commission, the SEC, the TSX or the NYSE of any order having the
effect of ceasing or suspending the distribution of the Offered Securities or the trading in any securities of the Company, or of the
institution or, to the knowledge of the Company, threatening of any proceeding for any such purpose; or |
| iii. | any requests made by any Canadian Securities Commission or the SEC for amending or supplementing any of
the Offering Documents or any Issuer Free Writing Prospectus or for additional information; |
and the Company will use its commercially
reasonable efforts to prevent the issuance of any order referred to in subparagraphs (b)i, (b)ii or (b)iii above and, if any such order
is issued, to obtain the withdrawal thereof at the earliest possible time;
| (c) | the Company will use its commercially reasonable efforts to obtain the conditional listing of the Offered
Securities on the TSX by the Closing Time, subject only to the official notice of issuance, and the Company will use its best efforts
to have the Offered Securities listed and admitted and authorized for trading on the NYSE by the Closing Time; |
| (d) | as soon as practicable, but in any event not later than eighteen months after the effective date of the
Registration Statement (as defined in Rule 158(c) under the U.S. Securities Act), the Company will make generally available
to its security holders an earnings statement or statements of the Company and its subsidiaries which will satisfy the provisions of Section 11(a) of
the U.S. Securities Act and Rule 158 under the U.S. Securities Act; |
| (e) | the Company will use the net proceeds from the Offering for the purposes described in the Pricing Disclosure
Package and the Final Prospectuses; |
| (f) | the Company will incur (or be deemed to incur) Qualifying Expenditures in an amount equal to the Commitment
Amount on or after the Closing Date and on or before the Termination Date in accordance with this Agreement and the Flow-Through Subscription
Agreements and renounce to the purchasers of Flow-Through Shares, with an effective date no later than the Termination Date, pursuant
to subsection 66(12.62) of the Tax Act ; |
| (g) | unless required to do so pursuant to subsection 66(12.73) of the Tax Act, the Company will not reduce
the amount renounced to the purchasers of Flow-Through Shares pursuant to subsection 66(12.62) of the Tax Act; |
| (h) | if the Company receives, or becomes entitled to receive, or may reasonably be expected to receive, any
assistance which is described in the definition of “assistance” in subsection 66(15) of the Tax Act and the receipt of or
entitlement or reasonable expectation to receive such assistance has or will have the effect of reducing the amount of Qualifying Expenditures
validly renounced to the purchasers of Flow-Through Shares to an amount less than the aggregate Commitment Amount, the Company will incur
(or be deemed to incur) additional Qualifying Expenditures using funds from sources other than the Commitment Amount in an amount equal
to such assistance, such that it is able to renounce Qualifying Expenditures equal to the Commitment Amount to the purchasers of Flow-Through
Shares pursuant to the Flow-Through Subscription Agreements; |
| (i) | the Company will not be subject to the provisions of subsection 66(12.67) of the Tax Act in a manner which
impairs its ability to renounce Qualifying Expenditures to the purchasers of Flow-Through Shares in an amount equal to the Commitment
Amount; |
| (j) | if the Company does not renounce to the purchasers of Flow-Through Shares effective on or before the Termination
Date Qualifying Expenditures equal to the Commitment Amount, the Company will indemnify and hold harmless the purchasers of Flow-Through
Shares and each of the partners thereof if the purchasers of Flow-Through Shares are a partnership (for the purposes of this paragraph
each an “Indemnified Person”) as to, and pay to the Indemnified Person an amount equal to the amount of any tax (as
referenced in paragraph (c) of the definition of an “excluded obligation” in subsection 6202.1(5) of the regulations
to the Tax Act) payable under the Tax Act (and under any corresponding provincial legislation) by any Indemnified Person as a consequence
of such failure on or before the 20th Business Day following the date the amount is determined. In the event that the amount
renounced by the Company to the purchasers of Flow-Through Shares is reduced pursuant to subsection 66(12.73) of the Tax Act, the Company
will indemnify and hold harmless each Indemnified Person as to, and pay to the Indemnified Person on or before the 20th Business
Day following the receipt, by an Indemnified Person, of a notice of assessment or reassessment issued by the CRA (or any corresponding
provincial tax authority) describing such reduction (the “Indemnified Person Assessment”) and communication in writing to
the Company (including a complete copy of the Indemnified Person Assessment), an amount equal to the amount of any tax (within the meaning
of the definition of “excluded obligation” in subsection 6202.1(5) of the regulations to the Tax Act) payable under the
Tax Act (and under the corresponding provincial legislation) by the Indemnified Person as a consequence of such reduction, provided that
nothing in this paragraph shall derogate from any other rights or remedies the purchasers of Flow-Through Shares may have at common law
with respect to liabilities other than those payable under the Tax Act and any corresponding provincial legislation. Notwithstanding the
foregoing, these indemnities shall have no force or effect and the purchasers of Flow-Through Shares shall not have any recourse or rights
of action to the extent that such indemnities, recourse or rights of action (a) to the extent that such indemnity, recourse or rights
of action would otherwise cause the Flow-Through Shares to be “prescribed shares” within the meaning of section 6202.1 of
the regulations to the Tax Act, or (b) if the purchasers of Flow-Through Shares participate in a Follow-On Transaction; |
| (k) | the Company will file with the CRA, within the time prescribed by subsection 66(12.68) of the Tax Act,
the forms prescribed for the purposes of such legislation together with a copy of the Flow-Through Subscription Agreements or any “selling
instrument” contemplated by such legislation; |
| (l) | the Company will deliver to the purchasers of Flow-Through Shares, before March 1, 2026, the relevant
Prescribed Forms (including form T101), fully completed and executed, renouncing to the purchasers of Flow-Through Shares, Qualifying
Expenditures in an amount equal to the Commitment Amount with an effective date of no later than the Termination Date, and such delivery
shall constitute the authorization of the Company to the purchasers of Flow-Through Shares to file such Prescribed Forms with the relevant
taxation authorities; |
| (m) | the Company will incur and renounce Qualifying Expenditures pursuant to the Flow-Through Subscription
Agreement and all other agreements with other persons providing for the issue of shares which are “flow-through shares” as
defined in subsection 66(15) of the Tax Act entered into by the Company on the Closing Date (collectively, the “Other Agreements”)
before incurring and renouncing any CDE pursuant to any other agreement which the Company may subsequently enter into after the Closing
Date with any Person with respect to the issue of shares which are “flow-through shares” as defined by subsection 66(15) of
the Tax Act. If the Company is required under the Tax Act or otherwise to reduce Qualifying Expenditures previously renounced to the purchasers
of Flow-Through Shares pursuant to the Flow-Through Subscription Agreement and unless a particular purchaser of Flow-Through Shares would
not be adversely affected or otherwise agrees, the reduction shall be made pro rata by the Commitment Amount of the purchaser of Flow-Through
Shares in relation to the aggregate Commitment Amount under this Subscription Agreement and the Other Agreements only after it has first
reduced to the extent possible all Qualifying Expenditures renounced to Persons (other than the purchasers of Flow-Through Shares) under
any agreements relating to shares which are “flow-through shares” as defined in subsection 66(15) of the Tax Act entered into
after the Closing Date; |
| (n) | upon the Company becoming aware of the fact that an amount purportedly renounced pursuant to the Flow-Through
Subscription Agreements exceeds the amount that it is entitled to renounce under the Tax Act, the Company will notify the purchasers of
Flow-Through Shares and comply with subsection 66(12.73) of the Tax Act, including the filing with the CRA of the statements contemplated
therein, a copy of which will be sent concurrently to the purchasers of Flow-Through Shares; |
| (o) | the Company will not enter into any other agreement which would prevent or restrict its ability to renounce
Qualifying Expenditures to the purchasers of Flow-Through Shares in the amount of the Commitment Amount; and |
| (p) | the Company will maintain proper, complete and accurate accounting books and records relating to the Commitment
Amount, the Qualifying Expenditures, the amounts renounced to the purchasers of Flow-Through Shares under this Agreement and the Flow-Through
Subscription Agreements and all transactions relating to the Qualifying Expenditures. The Company will retain all such books and records
as may be required to support the renunciation of Qualifying Expenditures contemplated by this Agreement and the Flow-Through Subscription
Agreements and, upon reasonable notice, shall make such books and records available for inspection and audit by or on behalf of the purchasers
of Flow-Through Shares, at the purchaser of such Flow-Through Shares’ sole expense. |
| (2) | Prior to the completion of the distribution of the Offered Securities, the Company will file all documents
required to be filed with or furnished to the Canadian Securities Commissions and the SEC pursuant to Applicable Securities Laws. |
| (3) | Except as contemplated by this Agreement, the Company will not, without the prior written consent of the
Lead Underwriter (not to be unreasonably withheld) on behalf of the Underwriters, directly or indirectly issue, offer, pledge, sell, contract
to sell, contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer,
lend or dispose of directly or indirectly, any Common Shares or securities convertible into or having the right to acquire Common Shares
or enter into any agreement or arrangement under which the Company would acquire or transfer to another, in whole or in part, any of the
economic consequences of ownership of Common Shares, or agree to become bound to do so, or disclose to the public any intention to do
so, during the period from the date hereof and ending 90 days following the Closing Date; provided that, notwithstanding the foregoing,
the Company may (i) grant options or other securities pursuant to the Company’s employee stock option plan or other equity
compensation plans provided that the exercise price thereof shall not be less than the Offering Price, and issue common shares upon the
exercise of such options or vesting of such securities, (ii) issue equity securities pursuant to the exercise or conversion, as the
case may be, of any warrants, incentive securities, or other convertible securities of the Company outstanding on the date hereof, or
(iii) issue equity securities in connection with one or more bona fide acquisitions by the Company in the normal course of business.
In addition, the Company shall not file a prospectus under Canadian Securities Laws or a registration statement under the U.S. Securities
Act in connection with any transaction by the Company or any person that is prohibited pursuant to the foregoing, except as pursuant to
the Offering and for registration statements on Form S-8 relating to employee benefit plans. |
| (4) | On or prior to the Closing Date for the Offering of the Flow-Through Shares, the Company will not amend
its constating documents nor will it split, consolidate, or reclassify the Common Shares. |
Section 12 |
All Terms to be Conditions |
The Company agrees that the
conditions contained in this Agreement will be complied with insofar as the same relate to acts to be performed or caused to be performed
by the Company. Any material breach or material failure to comply with any of the conditions set out in this Agreement shall entitle any
of the Underwriters to terminate their obligation to purchase the Offered Securities, by written notice to that effect given to the Company
and the other Underwriters at or prior to the Closing Time. It is understood that the Underwriters may waive, in whole or in part, or
extend the time for compliance with, any of such terms and conditions without prejudice to the rights of the Underwriters in respect of
any such terms and conditions or any other or subsequent breach or non-compliance, provided that to be binding on any Underwriter any
such waiver or extension must be in writing and signed by such Underwriter.
Section 13 |
Termination by Underwriters |
| (1) | Each Underwriter shall also be entitled to terminate its obligation to purchase the Offered Securities
by written notice to that effect to the Company and the other Underwriters at or prior to the Closing Time, if after the date hereof and
prior to the Closing Time: |
| (a) | there should occur any Material Change (as defined in the Securities Act (Ontario)) (actual, anticipated,
contemplated, threatened, financial or otherwise) in the assets, liabilities (contingent or otherwise), business, affairs or operations
of the Company and its subsidiaries, taken as a whole, or there should be discovered any previously undisclosed Material Fact (as defined
in the Securities Act (Ontario)) (other than an Material Fact related solely to any of the Underwriters) required to be disclosed
in the Pricing Disclosure Package or the Prospectuses or any amendment thereto, in each case which, in the reasonable opinion of the Underwriters
(or any of them), would be expected to have a significant adverse effect on the market price or value of the Common Share; or |
| (b) | there should develop, occur or come into effect or existence, any event, action, state, condition or major
financial occurrence of national or international consequence or any law or regulation or a change thereof which, in the opinion of the
Underwriters (or any of them) materially adversely affects or involves or will materially adversely affect or involve, the financial markets
or the business, operations or affairs of the Company and its subsidiaries, taken as a whole; or |
| (c) | any inquiry, action, suit, investigation or other proceeding in relation to the Company or any of
the directors or senior officers of the Company, whether formal or informal (including matters of regulatory transgression or unlawful
conduct), is commenced, threatened or publicly announced or any order is made under or pursuant to any statute or by any federal,
provincial, state, municipal or other governmental department, commission, board, bureau, stock exchange, regulatory authority,
agency or instrumentality or there is any enactment or change of law or regulation, or interpretation or administration thereof,
(unless solely based on the activities or alleged activities of the Underwriters), which in the reasonable opinion of the Underwriters
(or any of them), could operate to prevent or restrict the trading of the Common Shares, including the Offered Securities, or
which seriously adversely affects, or will, or could seriously adversely affect the market price or value of the Common Shares; or |
| (d) | the Company is in material breach of any term, condition or covenant of this Agreement or any representation
or warranty given by the Company in this Agreement becomes materially incorrect. |
| (2) | If this Agreement is terminated by any of the Underwriters pursuant to Section 13(1), there shall
be no further liability on the part of such Underwriter or of the Company to such Underwriter, except in respect of any liability which
may have arisen or may thereafter arise under Section 9, Section 10 and Section 17. |
| (3) | The right of the Underwriters or any of them to terminate their respective obligations under this Agreement
is in addition to such other remedies as they may have in respect of any default, act or failure to act of the Company in respect of any
of the matters contemplated by this Agreement. A notice of termination given by one Underwriter under this Section 13 shall not be
binding upon the other Underwriters. |
The closing of the purchase
and sale of the Offered Securities herein provided for shall be completed at 8:00 a.m. (Toronto time) on February 26, 2025,
or such other date and/or time as may be agreed upon in writing by the Company and the Underwriters, but in any event not later than February 28,
2025 (respectively, the “Closing Time” and the “Closing Date”), at the offices of Blake, Cassels &
Graydon LLP. In the event that the Closing Time has not occurred on or before February 28, 2025, this Agreement shall, subject to
Section 13(2) hereof, terminate.
Section 15 |
Conditions of Closing |
| (1) | The obligations of the Underwriters under this Agreement are subject to the accuracy of the representations
and warranties of the Company contained in this Agreement both as of the date of this Agreement and the Closing Time, the performance
by the Company of its obligations under this Agreement and receipt by the Underwriters or performance by the Company at the Closing Time
of the following, other than as provided below: |
| (a) | a favourable legal opinion, dated the Closing Date, in form and substance and subject to customary qualifications
and assumptions satisfactory to the Underwriters, acting reasonably, from Blake, Cassels & Graydon LLP, in its capacity as the
Company’s Canadian counsel, as to matters of Canadian federal and provincial law, addressed to the Underwriters and the Underwriters’
counsel; |
| (b) | a favourable legal opinion and negative assurance letter, dated the Closing Date, in form and substance
and subject to customary qualifications and assumptions satisfactory to the Underwriters, acting reasonably, from Skadden, Arps, Slate,
Meagher & Flom LLP, in its capacity as the Company’s U.S. counsel, addressed to the Underwriters; |
| (c) | a favourable legal opinion, dated the Closing Date, in form and substance satisfactory to the Underwriters,
from McCarthy Tétrault LLP as to title matters in respect of the Material Property; |
| (d) | a favourable legal opinion, dated the Closing Date, from Paul, Weiss, Rifkind, Wharton & Garrison
LLP, the Underwriters’ U.S. counsel, addressed to the Underwriters, in form and substance satisfactory to the Underwriters; |
| (e) | certificates or evidence of registration representing, in the aggregate, the Offered Shares (and Additional
Shares, if applicable) in the name of CDS or its nominee or in such other name(s) as the Lead Underwriter on behalf of the Underwriters
shall have directed; |
| (f) | KPMG LLP’s comfort letter, dated the Closing Date, updating the comfort letter referred to in Section 5(4) above
with such changes as may be necessary from the comfort letter delivered previously to bring the information therein forward to a date
which is within two (2) Business Days of the Closing Date; |
| (g) | the Underwriting Fee paid in accordance with the 14th paragraph of this Agreement; |
| (h) | on the Closing Date, evidence satisfactory to the Lead Underwriter that the Offered Securities (and Additional
Shares, if applicable) shall have been (A) approved for listing on the NYSE and (B) conditionally approved for listing on the
TSX, in each case, subject only to the official notice of issuance; |
| (i) | a certificate, dated the Closing Date, and signed on behalf of the Company, but without personal liability,
by the President and Chief Executive Officer and by the Chief Financial Officer of the Company, or such other officers of the Company
as may be reasonably acceptable to the Underwriters, certifying that: (i) the Company has complied with all covenants and satisfied
all terms and conditions hereof to be complied with and satisfied by the Company at or prior to the Closing Time; (ii) all the representations
and warranties of the Company contained herein are true and correct in all material respects as of the Closing Time with the same force
and effect as if made at and as of the Closing Time, after giving effect to the transactions contemplated hereby; (iii) there has
been no material change relating to the Company since the date hereof which has not been generally disclosed, except for the offering
of the Offered Securities, and with respect to which the requisite material change statement or report has not been filed and no such
disclosure has been made on a confidential basis; and (iv) that, to the best of the knowledge, information and belief of the persons
signing such certificate, no order, ruling or determination having the effect of ceasing or suspending trading in the Common Shares or
any other securities of the Company has been issued and no proceedings for such purpose are pending or are contemplated or threatened; |
| (j) | at the Closing Time, certificates dated the Closing Date, signed on behalf of the Company, but without
personal liability, by the President and Chief Executive Officer of the Company or another officer acceptable to the Underwriters, acting
reasonably, in form and content satisfactory to the Underwriters, acting reasonably, with respect to the constating documents of the Company;
the resolutions of the directors of the Company relevant to the Offering, including the allotment, issue (or reservation for issue) and
sale of the Offered Shares, the authorization of this Agreement, the listing of the Offered Shares and Additional Shares, on the TSX and
NYSE and transactions contemplated by this Agreement; and the incumbency and signatures of signing officers of the Company; |
| (k) | at the Closing Time, the Company’s directors and officers shall each have entered into lock-up agreements
in form and substance satisfactory to the Lead Underwriter, evidencing their agreement to not, without the consent of the Lead Underwriter,
which consent shall not be unreasonably withheld or delayed, offer, sell, or resell (or announce any intention to do so) any securities
of the Company held by them or agree to or announce any such offer or sale for a period of 90 days following the Closing Date, other than
in connection with a third party take-over bid made to all holders of Common Shares or a similar business combination transaction and
other than securities sold to satisfy tax obligations on the exercise of convertible securities of the Company held by such person; |
| (l) | at the Closing Time, a certificate of status (or equivalent) for the Company dated within one (1) Business
Day (or such earlier or later date as the Underwriters may accept) of the Closing Date; |
| (m) | the Company shall have accepted the duly and fully completed Flow-Through Subscription Agreements with
the subscribers of Flow-Through Shares and, unless the Company reasonably believes it would be unlawful or contrary to Applicable Securities
Laws to do so, have accepted each duly executed Flow-Through Subscription Agreement accompanied by the required subscription funds submitted
to the Company as contemplated by the Offering; and |
| (n) | such other documents as the Underwriters or counsel to the Underwriters may reasonably require. |
Section 16 |
Underwriters’ Option |
|
(1) |
The Underwriters’ Option may be exercised by the Underwriters at any time, in whole or in part, by delivering notice to the Company not later than 48 hours prior to the Closing Time, which notice will specify the number of Additional Shares to be purchased by the Underwriters. Subject to the terms of this agreement, upon the Underwriters furnishing this notice, the Underwriters will be committed to purchase, in the respective percentages set forth in Section 22, and the Company will be committed to issue and sell in accordance with and subject to the provisions of this Agreement, the number of Additional Shares indicated in the notice. |
| (2) | In the event that the Underwriter’s Option is exercised in accordance with its terms, the closing
of the issuance and sale of that number of Additional Shares in respect of which the Underwriters are exercising the Underwriters’
Option shall take place at the Closing Time at the offices of Blake, Cassels & Graydon LLP or at such other place as may be agreed
to by the Underwriters and the Company. |
| (3) | At the Closing Time, the Company shall issue to the Underwriters that number of Additional Shares in respect
of which the Underwriters have exercised the Underwriters’ Option and deposit with CDS or its nominee, if requested by the Lead
Underwriter, the Additional Shares electronically through the non-certificated inventory system of CDS against payment per Additional
Share by wire transfer or certified cheque payable to the Company or as otherwise directed by the Company. |
| (4) | Concurrently with the deliveries and payment under paragraph (3), the Company shall pay the Underwriting
Fee applicable to the Additional Shares in the manner provided in the 14th paragraph of this Agreement against delivery of a receipt for
that payment. |
| (5) | The obligation of the Underwriters to make any payment or delivery contemplated by this Section 16
is subject to the conditions set forth in Section 15. |
The Company will pay all expenses
and fees in connection with the Offering, including, without limitation: (i) all expenses of or incidental to the creation, issue,
sale or distribution of the Offered Securities and the filing of the Offering Documents; (ii) the fees and expenses of the Company’s
legal counsel; (iii) all costs incurred in connection with the preparation of documentation relating to the Offering; and (iv) all
reasonable and direct expenses of the Underwriters including all reasonable fees and disbursements of the Underwriters’ legal counsel,
up to a maximum amount of C$100,000 for the Underwriters’ Canadian counsel and US$200,000 for the Underwriters’ U.S. counsel,
plus applicable taxes and disbursements ((iv) collectively, the “Underwriters’ Expenses”). All Underwriters’
Expenses incurred by the Underwriters, or on their behalf, shall be payable by the Company immediately upon receiving an invoice therefor
from the Underwriters and shall be payable whether or not an offering is completed. At the option of the Lead Underwriter, such fees and
expenses may be deducted from the gross proceeds otherwise payable to the Company on the closing of the Offering. Regardless of whether
the transactions contemplated herein are completed or not, the Company will pay the Underwriters’ Expenses, as described in this
Section 17.
Section 18 |
No Advisory or Fiduciary Relationship |
The Company acknowledges and
agrees that (a) the purchase and sale of the Offered Securities pursuant to this Agreement, including the determination of the Offering
Price, the Offered Securities and any related discounts and commissions, is an arm’s-length commercial transaction between the Company,
on the one hand, and the several Underwriters, on the other hand, (b) in connection with the Offering and the process leading to
such transaction each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company or its
shareholders, creditors, employees or any other party, (c) no Underwriter has assumed or will assume an advisory or fiduciary responsibility
in favour of the Company with respect to the Offering or the process leading thereto (irrespective of whether such Underwriter has advised
or is currently advising the Company on other matters) and no Underwriter has any obligation to the Company with respect to the Offering
except the obligations expressly set forth in this Agreement, (d) the Underwriters and their respective affiliates may be engaged
in a broad range of transactions that involve interests that differ from those of the Company, and (e) the Underwriters have not
provided any legal, accounting, regulatory or tax advice with respect to the Offering and the Company has consulted its own legal, accounting,
regulatory and tax advisors to the extent it deems appropriate.
Any notice to be given hereunder
shall be in writing and may be given by hand delivery or email and shall, in the case of notice to the Company, be addressed and emailed
or delivered to:
|
Skeena Resources Limited |
|
Suite 2600 |
|
1133 Melville Street |
|
Vancouver, BC V6E 4E5 |
|
|
|
|
Attention: |
Walter Coles Jr. |
|
Email: |
wcoles@skeenaresources.com |
with a copy to (such copy not to constitute notice):
|
Blake, Cassels & Graydon LLP |
|
Suite 3500 |
|
1133 Melville Street |
|
Vancouver, British Columbia V6E 4E5 |
|
|
|
|
Attention: |
Kathleen Keilty and Bob Wooder |
|
Email: |
kathleen.keilty@blakes.com and bob.wooder@blakes.com |
and to (such copy not to constitute notice):
|
Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates |
|
222 Bay Street |
|
Suite 1750, P.O. Box 258 |
|
Toronto, ON M5K 1J5 |
|
|
|
|
Attention: |
Ryan Dzierniejko |
|
Email: |
ryan.dzierniejko@skadden.com |
and in the case of the Underwriters, to the Lead
Underwriter, addressed and emailed or delivered to:
|
BMO Nesbitt Burns Inc. |
|
100 King Street West |
|
Toronto, ON M5X 2A1 |
|
Canada |
|
|
|
|
Attention: |
Ilan Bahar |
|
Email: |
ilan.bahar@bmo.com |
with a copy to (such copy not to constitute notice):
|
Stikeman Elliott LLP |
|
Suite 1700 |
|
666 Burrard Street |
|
Vancouver, British Columbia V6C 2X8 |
|
|
|
|
Attention: |
Neville McClure |
|
Email: |
nmcclure@stikeman.com |
and to (such copy not to constitute notice):
|
Paul, Weiss, Rifkind, Wharton & Garrison LLP |
|
77 King Street West, |
|
Suite 3100, P.O. Box 226 |
|
Toronto, ON M5K 1J3 |
|
|
|
|
Attention: |
Christopher J. Cummings |
|
Email: |
ccummings@paulweiss.com |
The Company and the Underwriters may change their
respective addresses for notice by notice given in the manner referred to above.
Section 20 |
Actions on Behalf of the Underwriters |
All steps which must or may
be taken by the Underwriters in connection with this Agreement, with the exception of the matters contemplated by Section 9, Section 12
and Section 13, shall be taken by the Lead Underwriter on the Underwriters’ behalf and the execution of the Agreement by the
Underwriters shall constitute the Company’s authority for accepting notification of any such steps from, and for giving notice to,
and for delivering any definitive certificate(s) representing the Offered Securities to, or to the order of, the Lead Underwriter.
The representations, warranties,
obligations and agreements of the Company and of the Underwriters contained herein or delivered pursuant to this Agreement shall survive
the purchase by the Underwriters of the Offered Securities for a period of two years following the Closing Date and shall continue in
full force and effect notwithstanding any subsequent disposition by the Underwriters of the Offered Securities and the Underwriters shall
be entitled to rely on the representations and warranties of the Company contained in or delivered pursuant to this Agreement notwithstanding
any investigation which the Underwriters may undertake or which may be undertaken on the Underwriters’ behalf.
Section 22 | Underwriters’ Obligations |
| (1) | Subject to the terms of this Agreement, the Underwriters’ obligations under this Agreement to purchase
the Offered Securities shall be several and not joint and several and the liability of each of the Underwriters to purchase the Offered
Securities shall be limited to the following percentages of the purchase price paid for the Offered Securities: |
BMO Nesbitt Burns Inc. | |
| 35.0 | % |
Raymond James Ltd. | |
| 15.0 | % |
RBC Dominion Securities Inc. | |
| 15.0 | % |
Agentis Capital Markets LP | |
| 7.5 | % |
Canaccord Genuity Corp. | |
| 7.5 | % |
CIBC World Markets Inc. | |
| 7.5 | % |
Desjardins Securities Inc. | |
| 7.5 | % |
TD Securities Inc. | |
| 5.0 | % |
| |
| 100 | % |
*The Lead Underwriter is entitled to a “step-up fee”
equal to 5% of the Underwriting Fee, which is payable by the Company as part of and not in addition to the Underwriting Fee.
| (2) | If any of the Underwriters fails to purchase its applicable percentage of the Offered Securities at the
Closing Time (a “Defaulting Underwriter”) and the percentage of Offered Securities that have not been purchased by
the Defaulting Underwriter represents 10% or less of the Offered Securities then the other Underwriters will be severally, and not jointly
and severally, obligated to purchase, on a pro rata basis to their respective percentages as aforesaid, all but not less than all of the
Offered Securities not purchased by the Defaulting Underwriter, and to receive the Defaulting Underwriter’s portion of the Underwriting
Fee in respect thereof, and such non-defaulting Underwriters shall have the right, by notice to the Company, to postpone the Closing Date,
by not more than three Business Days to effect such purchase. In the event that the percentage of Offered Securities that have not been
purchased by a Defaulting Underwriter represents more than 10% of the aggregate Offered Securities, the other Underwriters will have the
right, but will not be obligated, to purchase all of the percentage of the Offered Securities which would otherwise have been purchased
by the Defaulting Underwriter; the Underwriters exercising such right will purchase such Offered Securities, if applicable, pro rata to
their respective percentages aforesaid or in such other proportions as they may otherwise agree. In the event that such right is not exercised,
the non-defaulting Underwriters shall be relieved of all obligations to the Company arising from such default. Nothing in this section
shall oblige the Company to sell to the Underwriters less than all of the Offered Securities or relieve from liability to the Company
any Underwriter which shall be so in default. |
Section 23 |
Market Stabilization |
In connection with the distribution
of the Offered Securities, the Underwriters (or any of them) may effect transactions which stabilize or maintain the market price of the
Common Shares at levels other than those which might otherwise prevail in the open market, but in each case as permitted by Applicable
Securities Laws. Such stabilizing transactions, if any, may be discontinued by the Underwriters at any time.
Section 24 |
Entire Agreement |
Any and all previous agreements
with respect to the purchase and sale of the Offered Securities, whether written or oral, are terminated and this Agreement constitutes
the entire agreement between the Company and the Underwriters with respect to the purchase and sale of the Offered Securities.
This Agreement shall be governed
by and construed in accordance with the laws in force in the province of British Columbia and the federal laws of Canada applicable therein.
Section 26 |
Time of the Essence |
Time shall be of the essence
of this Agreement. This Agreement may be executed in counterparts, each of which when so executed shall be deemed to be an original and
such counterparts together shall constitute one and the same instrument.
[Remainder of page intentionally blank.
Signature page follows.]
If the foregoing is in accordance
with your understanding and is agreed to by you, will you please confirm your acceptance by signing the enclosed copies of this letter
at the place indicated and returning the same to us.
Yours very truly,
BMO NESBITT BURNS INC.
By: |
"(signed) Ilan Bahar" |
|
Name: |
Illan Bahar |
|
Title: |
Managing Director and Co-head Global Metals and Mining |
|
RAYMOND JAMES LTD.
By: |
"(signed) Gavin McOuat" |
|
Name: |
Gavin McOuat |
|
Title: |
Senior Managing Director |
|
RBC DOMINION SECURITIES INC.
By: |
"(signed) Michael Scott" |
|
Name: |
Michael Scott |
|
Title: |
Managing Director |
|
AGENTIS CAPITAL MARKETS LP
By: |
"(signed) Robert Van Belle" |
|
Name: |
Robert Van Belle |
|
Title: |
CEO |
|
CANACCORD GENUITY CORP.
By: |
"(signed) David Sadowski" |
|
Name: |
David Sadowski |
|
Title: |
Managing Director, Head of Canadian Metals and Mining |
|
CIBC WORLD MARKETS INC.
By: |
"(signed) Shaun Silveira" |
|
Name: |
Shaun Silveira |
|
Title: |
Executive Director |
|
DESJARDINS SECURITIES INC.
By: |
"(signed) Marc Mills" |
|
Name: |
Marc Mills |
|
Title: |
Managing Director |
|
TD SECURITIES INC.
By: |
"(signed) Fraser Ince" |
|
Name: |
Fraser Ince |
|
Title: |
Director |
|
The foregoing is in accordance with our understanding
and is accepted by us.
SKEENA RESOURCES LIMITED
By: |
"(signed) Andrew MacRitchie" |
|
Name: |
Andrew MacRitchie |
|
Title: |
Chief Financial Officer |
|
SCHEDULE “A”
PRICING TERMS INCLUDED IN THE PRICING DISCLOSURE
PACKAGE
Number of Offered Shares Offered by the Company: 4,800,000
Number of Additional Shares Offered by the Company: 720,000
Public Offering Price per Common Share: $14.70
Underwriting Commission per Offered Share: 5%
Date of Delivery of Offered Shares: February 26, 2025
Term sheet dated February 18, 2025, substantially in the form
of Schedule “A-1”
ISSUER FREE WRITING PROSPECTUSES
None
SCHEDULE “A” - I
TERM SHEET
[See attached.]
Skeena Resources Limited
Treasury Offering of Common Shares
February 18,
2025
The Common Shares will be offered by way of a prospectus supplement in each of the provinces of Canada, except
Quebec, and in the United States. A final base shelf prospectus containing important information relating to the Securities has been
filed with the securities regulatory authorities in each of the provinces of Canada, excluding Quebec, and a corresponding registration
statement on Form F-10 has been filed with the U.S. Securities and Exchange Commission. A copy of the final base shelf prospectus,
any amendment to the final base shelf prospectus and any applicable shelf prospectus supplement that has been filed, is required to be
delivered with this term sheet.
This term sheet does not provide full disclosure of all material facts relating to the Securities.
Investors should read the final base shelf prospectus, any amendment and any applicable shelf prospectus supplement for disclosure of
those facts, especially risk factors relating to the Securities, before making an investment decision.
Terms and Conditions |
|
Issuer: |
Skeena Resources Limited (the “Company” or “you”). |
|
|
Offering: |
Treasury offering of 4,800,000 common shares of the Company (the “Common Shares”). |
|
|
Flow-Through Election |
The Underwriters may elect, at any time up to 48 hours prior to Closing, to have up to 2,230,000 Common Shares issuable under the Offering (including any Common Shares issuable upon exercise of the Underwriters’ Option) to be issued as “flow-through shares” within the meaning of the Income Tax Act (Canada) (“Flow-Through Common Shares” and together with the Common Shares, the “Offered Shares”) at a price of C$17.93 per Flow-Through Common Share.
The Underwriters will redistribute any Flow-Through Common Shares (“Re-Offer Common Shares”) at the Re-Offer Price (as defined below). |
|
|
Offering Price: |
C$14.70 per Common Share
C$17.93 per Flow-Through Common Share |
|
|
Re-Offer Price: |
C$14.70 per Re-Offer Common Share (the “Re-Offer Price”). |
|
|
Offering Amount: |
C$70,560,000 assuming the offering consists entirely of the sale of Common Shares, excluding the Underwriters’ Option.
If the Underwriters were to make the Flow-Though Election in full, aggregate gross proceeds to the Company of the Offering would be C$77,762,900. |
|
|
Underwriters’ Option: |
The Company has granted the Underwriters an option, exercisable in whole or in part, at any time up to 48 hours prior to Closing, to increase the size of the Offering by up to 15% (the “Underwriters’ Option”). If the Underwriters exercise the Underwriters’ Option, they may elect how many of the shares issued pursuant to such exercise will be Common Shares and/or Flow-Through Common Shares. |
|
|
Use of Proceeds: |
The proceeds raised from the sale of Common Shares will be used for continued advancement of the Company’s Eskay Creek
gold-silver project and for general corporate purposes. |
|
|
|
Any proceeds raised from the sale of Flow-Through Common Shares will be used to incur Qualifying Expenditures (defined below) as set forth below under “Flow-Through Common Shares Income Tax Considerations”. |
Skeena Resources Limited
Treasury Offering of Common Shares
February 18,
2025
Flow-Through Common Shares Income Tax Considerations: |
The Company, pursuant to the provisions in the Income Tax Act (Canada), (i) shall, in the case of the Flow-Through Common Shares, incur resource development expenses that are described in paragraph (c.2) of the definition of “Canadian development expense” in subsection 66.2(5) of the Income Tax Act (Canada) or that would be described in paragraph (f) of such definition if the reference therein to “paragraphs (a) to (e)” were a reference to “paragraph (c.2)” (“CDE”) after the closing date and prior to December 31, 2025 in the aggregate amount of not less than the total amount of the gross proceeds raised from the issue of Flow-Through Common Shares. The Company shall renounce CDE so incurred to the purchasers of Flow-Through Common Shares with an effective date of no later than December 31, 2025 in accordance with the Income Tax Act (Canada). In the event that the Company is unable to renounce $17.93 per Flow-Through Common Share of CDE effective on or prior to December 31, 2025 for each Flow-Through Common Share purchased, the Company will as sole recourse for such failure to renounce, indemnify each Flow-Through Common Share subscriber for the additional federal, provincial and territorial taxes, as applicable, payable by such subscriber to the extent permitted by the Income Tax Act (Canada) as a result of the Company’s failure to renounce CDE as agreed. |
|
|
Form of Offering: |
Bought deal by way of a prospectus supplement to be filed in all provinces of Canada, excluding Quebec. Registered public offering in the U.S. via MJDS. |
|
|
Listing: |
An application will be made to list the Offered Shares on the Toronto Stock Exchange (the “TSX”) and on the New York Stock Exchange (the “NYSE”). The existing common shares are listed on the TSX and the NYSE under the symbol “SKE”. |
|
|
Sole Bookrunner: |
BMO Capital Markets. |
|
|
Commission: |
5.0% on the gross proceeds to the Company |
|
|
Closing: |
February 26, 2025. |
Copies of the Company’s base shelf prospectus dated January 31, 2023, Registration Statement on Form F-10 and prospectus supplements relating to the Offering, when available, may be obtained upon request in Canada by contacting BMO Nesbitt Burns Inc. (“BMO Capital Markets”), Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 by telephone at 905-791-3151 Ext 4312 or by email at torbramwarehouse@datagroup.ca, and in the United States by contacting BMO Capital Markets Corp., Attn: Equity Syndicate Department, 151 W 42nd Street, 32nd Floor, New York, NY 10036, or by telephone at (800) 414-3627 or by email at bmoprospectus@bmo.com. Copies of the base shelf prospectus and prospectus supplement, when available, can be found under the Company’s profile on SEDAR+ at www.sedarplus.ca, and a copy of the registration statement and the prospectus supplement can be found on EDGAR at www.sec.gov.
SCHEDULE “B”
FORM OF SUBSCRIPTION AND RENUNCIATION AGREEMENT
FOR FLOW-THROUGH SHARES
| TO: | SKEENA RESOURCES LIMITED (the “Company”) |
| (1) | Each of those persons listed on Appendix “A”
attached hereto (the “Subscribers”) and in the respective numbers set out thereon, by ______________________, as their
duly authorized agent (the “Agent”) hereby subscribes for common shares in the capital of the Company (“Shares”)
to be issued as “flow-through shares” as defined in subsection 66(15) of the Tax Act (as defined herein) by the Company for
an aggregate consideration of $__________________________, representing a subscription price of $[●]
per Share, upon the terms and subject to the conditions set forth in the agreement constituted by the acceptance thereof (the “Subscription
Agreement”) and as described in the Company’s final short form base shelf prospectus dated January 31, 2023 and the
final prospectus supplement dated February [●], 2025 (together,
the “Prospectus”). The Agent shall tender payment on behalf of the Subscribers of the aggregate subscription price
for __________________________ Shares in the sum of $__________________________ on the Closing Date (as defined herein), such amount forming
a portion of the aggregate proceeds payable to the Company on the Closing Date pursuant to an underwriting agreement among the Company,
BMO Nesbitt Burns Inc., [●], [●],
[●], and [●]
dated February [●], 2025 (the “Underwriting Agreement”). |
Whenever used in this Subscription Agreement,
unless there is something in the subject matter or context inconsistent therewith, the following words and phrases have the respective
meanings ascribed to them as follows:
| (a) | “Canadian Development Expense” means a “Canadian development expense” as
defined in subsection 66.2(5) of the ITA, other than amounts which are: |
| i. | assistance described in paragraph 66(12.62)(a) of the ITA; |
| ii. | prescribed to be Canadian exploration and development overhead expenses for the purposes of paragraph
66(12.62)(b) of the ITA; |
| iii. | any expense described in paragraph 66(12.62)(b.1); |
| iv. | specified expenses that are described in paragraph (e) of the definition of “Canadian development
expense” in subsection 66.2(5) of the ITA or that are described in paragraph (f) of that definition because of the reference
in the latter paragraph to paragraph (e); or |
| v. | any expense for prepaid services or rent that do not qualify as outlays and expenses for the period as
described in the definition of "expense" in subsection 66(15) of the ITA; |
| (b) | “CRA” means the Canada Revenue Agency; |
| (c) | “Expenditure Period” means the period commencing on the Closing Date, and ending on
December 31, 2025; |
| (d) | “Flow-Through Funds” means the aggregate subscription proceeds received by the Corporation
from the Subscriber for the subscription of the Shares by the Subscriber, being $8.3181 per Share; |
| (e) | “Follow-On Transaction” has the meaning set out in Section 1(5)(i) of this
Agreement; |
| (f) | “ITA” means the Income Tax Act (Canada) together with any and all regulations promulgated
thereunder and any proposed amendments thereto announced publicly by or on behalf of the Minister of Finance (Canada) prior to the date
of this Subscription Agreement; |
| (g) | “ITR” means the Income Tax Regulations (Canada) together with any proposed amendments
thereto announced publicly by or on behalf of the Minister of Finance (Canada) prior to the date of this Subscription Agreement; |
| (h) | “Prescribed Forms” means the forms prescribed from time to time under subsection 66(12.7)
of the ITA, filed or to be filed by the Corporation within the prescribed time renouncing the Qualifying Expenses to the Subscriber pursuant
to this Subscription Agreement and all parts or copies of such forms required by the CRA, when applicable, to be delivered to the Subscriber; |
| (i) | “QTA” means the Taxation Act (Québec), together with any and all regulations
promulgated thereunder, and any proposed amendments thereto announced publicly by or on behalf of the Ministre des Finances (Québec)
prior to the date of this Subscription Agreement; and |
| (j) | “Qualifying Expenses” means expenses which are (i) Canadian Development Expenses
and (ii) described in the definition of “accelerated Canadian development expense” in subsection 66.2(5) of the
ITA, which are incurred (or deemed to be incurred) by the Corporation during the Expenditure Period, which may be renounced by the Corporation
pursuant to subsection 66(12.62) of the ITA with an effective date not later than December 31, 2025, and in respect of which, but
for the renunciation, the Corporation would be entitled to a deduction from income for purposes of the ITA. For clarity, any obligation
of the Corporation to renounce an amount of Qualifying Expenditures to the Subscriber with respect to a Share under the ITA includes,
for the purposes of Québec income taxation, an obligation to renounce such amount under the QTA. |
| (k) | “Termination Date” means December 31, 2025. |
Any reference to the ITA or a provision
thereof shall include, for the purposes of Québec income taxation, a reference to the QTA or the equivalent provision thereof,
if any. Any reference to a filing or similar requirement imposed under the ITA shall include, for the purposes of Québec income
taxation, a reference to the equivalent filing or similar requirement, where applicable, under the QTA; provided that if no filing or
similar requirement is provided under the QTA, a copy of any material relating to the Shares or the Subscriber filed under the Tax Act
shall be filed with the Agence du revenu du Québec. Without limiting the generality of the foregoing, an obligation of the Corporation
to renounce an amount of Qualifying Expenses to the Subscriber with respect to a Flow-Through Share under the ITA shall include, for the
purposes of Québec income taxation, an obligation to renounce such amount under the QTA.
| (3) | Corporation’s Representations, Warranties and Covenants. |
By executing this Subscription Agreement,
the Corporation represents, warrants and covenants to and with the Subscriber (and acknowledges that the Subscriber is relying thereon)
that:
| (a) | all Canadian Development Expenses renounced by the Corporation to the Subscriber (or beneficial purchaser)
pursuant to this Subscription Agreement will be Qualifying Expenses, and the Corporation shall perform and carry out all acts and things
to be completed by it as provided in this Subscription Agreement; |
| (b) | except as a result of any agreement, arrangement, undertaking or understanding to which the Corporation
is not a party, the Shares, at the time of issuance, will qualify as “flow-through shares” as defined in subsection 66(15)
of the ITA and will not be “prescribed shares” as defined in section 6202.1 of the ITR; |
| (c) | if the Corporation amalgamates with one or more companies, any shares issued to or held by the Subscriber
(or beneficial purchaser) as a replacement for the Shares as a result of such amalgamation will qualify, by virtue of subsection 87(4.4)
of the ITA, as “flow-through shares” as defined in subsection 66(15) of the ITA and in particular will not be “prescribed
shares” as defined in section 6202.1 of the ITR; |
| (d) | the Corporation has no reason to believe that it will be unable to incur, on or after the Closing Date
and on or before the Termination Date or that it will be unable to renounce to the Subscriber effective December 31, 2025, Qualifying
Expenses in an aggregate amount equal to the Flow-Through Funds and the Corporation has no reason to expect any reduction of such amount
by virtue of subsection 66(12.73) of the ITA; |
| (e) | the Corporation will, upon the effective date of any renunciation of Canadian Development Expenses pursuant
hereto, have, or be deemed to have, sufficient “cumulative Canadian development expenses” as defined in subsection 66.2(5) to
enable it to make the renunciation; |
| (f) | the Corporation will not be subject to the provisions of subsection 66(12.67) of the ITA in a manner which
impairs its ability to renounce Canadian Development Expenses to the Subscriber (or beneficial purchaser) in an amount equal to the Flow-Through
Funds; |
| (g) | the Corporation is and will at all material times remain a “principal-business corporation”
as defined in subsection 66(15) of the ITA; |
| (h) | the Corporation has never been in default of any of its legal obligations in respect of any "flow-through
share" financings previously undertaken by the Corporation; and |
| (i) | the Corporation will maintain proper accounting books and records relating to the Canadian Development
Expenses incurred by it pursuant to this Subscription Agreement. |
| (4) | Representations and Warranties of the Subscriber. |
By executing this Subscription Agreement,
the Subscriber represents, warrants and covenants (on its own behalf and, if applicable, on behalf of those (including each beneficial
purchaser, if any) for whom the Subscriber is contracting hereunder) to and with the Corporation (and acknowledges that the Corporation
and its counsel are relying thereon) that:
| (a) | the Subscriber and any beneficial purchaser for whom the Subscriber is acting as trustee or agent, and
if the Subscriber is a partnership, its members, deal, and at all relevant times will continue to deal, at arm’s length with the
Corporation for the purposes of the ITA; |
| (b) | the Subscriber or, any beneficial purchaser for whom the Subscriber is contracting hereunder, as the case
may be, has not and does not expect to receive any financial assistance from the Corporation, directly or indirectly, in respect of the
purchase of the Shares; |
| (c) | neither the Subscriber nor any beneficial purchaser for whom the Subscriber is contracting hereunder,
as the case may be, has entered or will enter into any agreement, arrangement, undertaking or understanding which will cause the Shares
to be or become “prescribed shares” for the purposes of section 6202.1 of the ITR. The Corporation shall not be liable or
responsible for any breach of any representation, warranty or covenant given in this Subscription Agreement resulting from the Shares
being “prescribed shares” as a result of any transaction, agreement or arrangement entered into by the Subscriber; |
| (d) | the Subscriber and any beneficial purchaser for whom the Subscriber is acting as trustee or agent, and
if the Subscriber is a partnership, its members, will fully comply with any request for relevant information by the Corporation that is
necessary to comply with all filing requirements of the ITA in respect of this Subscription Agreement and all other requirements
of the ITA and any applicable provincial or territorial tax legislation with respect to the renunciation of Qualifying Expenses;
and |
| (e) | neither the Subscriber nor any beneficial purchaser for whom the Subscriber is contracting hereunder,
as the case may be, is a non-resident of Canada for the purposes of the ITA. |
| (5) | Provisions Relating to Flow-Through Shares and Qualifying Expenses. |
| (a) | The Subscriber, on its own behalf and on behalf of any beneficial purchaser for whom it is acting as trustee
or agent, acknowledges that any interest accruing on Flow-Through Funds will accrue to the sole benefit of the Corporation and may be
applied by the Corporation for general corporate purposes. |
| (b) | Except as otherwise expressly provided in this Subscription Agreement, the Corporation will incur or be
deemed to incur, by no later than the expiry of the Expenditure Period, Qualifying Expenses in the amount equal to the Flow-Through Funds. |
| (c) | The Corporation will renounce to the Subscriber (or any beneficial purchaser), with an effective date
or effective dates not later than December 31, 2025, and not before the Qualifying Expenses have been incurred (or been deemed to
have incurred), pursuant to subsection 66(12.62) of the ITA, Qualifying Expenses in an amount equal to the Flow-Through Funds. |
| (d) | The Corporation shall deliver to the Subscriber, by March 15, 2026, the relevant Prescribed Forms
(including a Statement of Resource Expenses (T101) for each Subscriber as well as Relevé 11 forms for Subscribers resident in or
otherwise subject to taxation in Québec), fully completed and executed, renouncing to the Subscriber Qualifying Expenses in an
amount equal the Flow-Through Funds with an effective date of no later than December 31, 2025, such delivery constituting the authorization
of the Corporation to the Subscriber to file such Prescribed Forms with the relevant taxation authorities. |
| (e) | Unless required to do so pursuant to subsection 66(12.73) of the ITA, the Corporation shall not reduce
the amount renounced to the Subscriber pursuant to subsection 66(12.62) of the ITA. |
| (f) | If the Corporation receives, becomes entitled to receive, or may reasonably be expected to receive, any
“assistance” (as defined in subsection 66(15) of the ITA) and the receipt of or entitlement or reasonable expectation to receive
such assistance has or will have the effect of reducing the amount of Qualifying Expenses validly renounced to the Subscriber hereunder
to less than the aggregate amount of the Flow-Through Funds, the Corporation will incur (or be deemed to incur) additional Qualifying
Expenses using funds from other sources such that it is able to renounce Qualifying Expenses in an amount not less than the aggregate
amount of the Flow-Through Funds to the Subscriber pursuant to this Subscription Agreement. |
| (g) | The Corporation will incur (or be deemed to incur) and renounce Qualifying Expenses pursuant to this Subscription
Agreement and all other agreements with other persons providing for the Corporation to issue “flow-through shares” as defined
in subsection 66(15) of the ITA entered into by the Corporation on the Closing Date (collectively the “Other Agreements”)
before incurring (or being deemed to incur) and renouncing Qualifying Expenses pursuant to any other agreement which the Corporation may
subsequently enter into with any person with respect to the issue of shares or rights which are “flow-through shares” as defined
in subsection 66(15) of the ITA. If the Corporation is required under the ITA or otherwise to reduce Qualifying Expenses previously renounced
to the Subscriber and unless the Subscriber otherwise agrees, the reduction shall be made pro rata by the number of common shares that
are “flow-through shares” issued or to be issued pursuant to this Subscription Agreement and the Other Agreements only after
it has first reduced to the extent possible all Qualifying Expenses renounced to persons (other than the Subscriber and the subscribers
under the Other Agreements) under any agreements relating to shares which are “flow-through shares” as defined in subsection
66(15) of the ITA entered into after the Closing Date. |
| (h) | If the Corporation does not renounce to the Subscriber effective on or before December 31, 2025 Qualifying
Expenses in an amount equal to the Flow-Through Funds, the Corporation shall indemnify and hold harmless the Subscriber and each of the
partners thereof if the Subscriber is a partnership (for the purposes of this paragraph each an “Indemnified Person”) as to,
and pay to the Indemnified Person an amount equal to the amount of any tax (as referenced in paragraph (c) of the definition of an
“excluded obligation” in subsection 6202.1(5) of the ITR) payable under the ITA (and under any corresponding provincial
legislation) by any Indemnified Person as a consequence of such failure on or before the 20th Business Day following the date
the amount is determined. In the event that the amount of Qualifying Expenses renounced by the Corporation to the Subscriber is reduced
pursuant to subsection 66(12.73) of the ITA, the Corporation shall indemnify and hold harmless each Indemnified Person as to, and pay
to the Indemnified Person on or before the 20th Business Day following the receipt, by an Indemnified Person, of a notice of
assessment or reassessment issued by the CRA (or any corresponding provincial tax authority) describing such reduction (the “Indemnified
Person Assessment”) and communication in writing to the Corporation (including a complete copy of the Indemnified Person Assessment),
an amount equal to the amount of any tax (within the meaning of the definition of “excluded obligation” in subsection 6202.1(5) of
the ITR) payable under the ITA (and under the corresponding provincial legislation) by the Indemnified Person as a consequence of such
reduction, provided that nothing in this paragraph shall derogate from any rights or remedies the Subscriber (or beneficial purchaser)
may have at common law with respect to liabilities other than those payable under the ITA and any corresponding provincial legislation.
Notwithstanding the foregoing, this indemnity shall have no force or effect and the Subscriber shall not have any recourse or rights of
action (a) to the extent that such indemnity, recourse or rights of action would otherwise cause the Shares to be “prescribed
shares” as defined in section 6202.1 of the ITR, or (b) if the Subscriber, or any beneficial purchaser for whom the Subscriber
is contracting hereunder, as the case may be, participates in a Follow-On Transaction. To the extent that any person entitled to be indemnified
hereunder is a disclosed principal in this Subscription Agreement, the Subscriber shall obtain and hold the rights and benefits of this
Subscription Agreement in trust for, and on behalf of, such person and such person (or the Subscriber on such person’s behalf) shall
be entitled to enforce the provisions of this Subscription Agreement notwithstanding that such person is not a party to this Subscription
Agreement. |
| (i) | In determining whether the Subscriber (or beneficial purchaser) deals at arm’s length with the Corporation
for the purposes of this Subscription Agreement, the Corporation may rely on the representation and warranty given by the Subscriber in
Section 1(4)(a) of this Subscription Agreement but shall not be bound thereby where the Corporation has knowledge of other relevant
facts. The Corporation shall not be liable to indemnify the Subscriber (or any beneficial purchaser) for any amounts of tax payable by
the Subscriber (or any beneficial purchaser) as a result of a misrepresentation by the Subscriber (or any beneficial purchaser) that the
Subscriber (or any beneficial purchaser) deals at arm’s length with the Corporation. |
| (j) | If the Subscriber or, if applicable, any beneficial purchaser for whom the Subscriber is contracting hereunder,
as the case may be, is acquiring the Shares with the intention of selling the Shares to a third party (a “Follow-On Transaction”),
then the Subscriber and, if applicable, any beneficial purchaser for whom the Subscriber is contracting hereunder, as the case may be,
acknowledges and confirms that, notwithstanding any provision of this Subscription Agreement, the Subscriber and, if applicable, any beneficial
purchaser for whom the Subscriber is contracting hereunder, is not relying on the Corporation or its legal counsel regarding any representations,
warranties and indemnities in respect of the tax consequences or potential tax benefits of investment in the Shares and participating
in the Follow-On Transaction, including any risk that the Follow-On Transaction, in and of itself, may cause the Shares to be “prescribed
shares” within the meaning of section 6202.1 of the ITR. |
| (k) | Upon the Corporation becoming aware of the fact that an amount purportedly renounced pursuant to this
Subscription Agreement exceeds the amount that it is entitled to renounce under the ITA, the Corporation will notify the Subscriber and
comply with subsection 66(12.73) of the ITA, including the filing with the CRA of the statement contemplated therein, a copy of which
will be sent concurrently to the Subscriber. |
| (l) | The Corporation will file the prescribed form referred to in subsection 66(12.68) of the ITA, together
with a copy of this Subscription Agreement or any “selling instrument” contemplated by that subsection, with the CRA on or
before the last day of the month following the earlier of: |
| i. | the month in which this Subscription Agreement was made; and |
| ii. | the month in which this Subscription Agreement or other selling instrument is first delivered to a potential
investor pursuant to the offering contemplated by the prospectus placement. |
| (6) | The Subscriber represents and warrants that the funds representing the aggregate subscription price for
the Shares subscribed for hereunder which will be advanced by the Subscriber, or, if applicable, by the Agent on behalf of the Subscriber,
to the Company hereunder will not represent proceeds of crime for the purpose of the Proceeds of Crime (Money Laundering) and Terrorist
Financing Act (Canada) (the “PCMLTF Act”) and the Subscriber acknowledges that the Company may in the future be
required by law to disclose the Subscriber’s name and other information relating to this Subscription Agreement and the Subscriber’s
subscription hereunder, on a confidential basis, pursuant to the PCMLTF Act. To the best of the Subscriber’s knowledge, none of
the subscription funds to be provided hereunder (a) have been or will be obtained or derived, directly or indirectly, from or related
to any activity that is deemed illegal under the laws of Canada or the United States or any other jurisdiction, or (b) are being
tendered on behalf of a person or entity who has not been identified to the Subscriber. The Subscriber shall promptly notify the Company
if the Subscriber discovers that any such representation ceases to be true, and shall provide the Company with appropriate information
in connection therewith. |
| (7) | Nothing herein shall constitute or be construed to constitute a partnership of any kind whatsoever between
the Subscribers or any of them and the Company. |
| (8) | This Subscription Agreement shall be governed by and construed in accordance with the laws in force in
the province of British Columbia and the federal laws of Canada applicable therein. |
| (9) | Time shall be of the essence hereof. |
| (10) | The representations, warranties, obligations and agreements of the Company contained in this Subscription
Agreement or in connection with the purchase and sale of the Shares shall survive the purchase of the Shares, the termination of this
Subscription Agreement and the distribution of the Shares pursuant to the Prospectus and shall continue in full force and effect for such
maximum period of time as any Subscriber may be entitled to commence an action, or exercise a right of rescission, with respect to a misrepresentation
contained or incorporated by reference in the Prospectus pursuant to applicable securities laws, for the benefit of the Subscriber, provided
that the representations, warranties and covenants of the Company relating to tax matters contained in this Subscription Agreement shall
survive the closing and continue in full force and effect for the benefit of the Subscriber until expiry of a period of 60 days after
the date on which the applicable limitation period expires for action by the applicable taxation authorities. |
| (11) | The subscriptions of the Subscribers are further subject to any rights available to the Subscribers under
applicable securities laws. |
| (12) | This Subscription Agreement shall be binding on and enure to the benefit of the Subscribers and the Company
and their respective heirs, executors, administrators, successors and assigns. |
| (13) | In the event of a conflict between the provisions of this Subscription Agreement and the provisions of
the Underwriting Agreement, this Subscription Agreement shall prevail. |
[Signature page follows.]
DATED at the City of ____________________, in the Province of___________________,
this _____ day of _________________________, 2025.
|
|
[●], as the duly authorized agent of the Subscribers |
|
|
|
|
By: |
|
This Subscription Agreement is accepted and agreed
to by the Company at the City of __________________________, in the Province of _______________________________, this _______ day of __________________________,
2025.
|
|
SKEENA RESOURCES LIMITED |
|
|
|
|
By: |
|
|
|
Name: |
|
|
Title: |
EXHIBIT “A” TO SCHEDULE “C”
OF THE SUBSCRIPTION AND RENUNCIATION AGREEMENT
Name and Address
of Subscriber |
Social Insurance,
Corporate Tax
Account or Tax
Shelter Number |
Number of Shares
Subscribed For |
Aggregate
Subscription
Amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skeena Resources (NYSE:SKE)
Historical Stock Chart
From Jan 2025 to Feb 2025
Skeena Resources (NYSE:SKE)
Historical Stock Chart
From Feb 2024 to Feb 2025